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ABSTRACT 
The domestic chicken is an attractive, but underutilized, animal model for studies 
of adipose tissue biology, metabolism and obesity: 1.) like humans, chickens rely on liver 
rather than adipose tissue for the majority of de novo lipogenesis; 2.) quantitative trait 
loci (QTLs) linked to fatness in chickens contain genes implicated in human 
susceptibility to obesity and diabetes; 3.) chickens are naturally hyperglycemic and 
insulin resistant; and 4.) a broad selection of genetic models exhibiting a range of fatness 
are available. To date, however, little is known about regulation of adipose metabolism in 
this model organism.  
Affymetrix arrays were used to profile gene expression in abdominal adipose 
tissue from broiler chickens fed ad libitum or fasted for five hours. Quantitative real time 
polymerase chain reaction (QPCR) was used to validate microarray results for select 
genes. A total of 1780 genes were differentially expressed in fasted vs. ad libitum fed 
(p<0.05) tissue after correction for multiple testing. Gene Ontology and pathway analyses, 
combined with Western blot validation, indicated significant effects on a broad selection 
of pathways related to metabolism, stress signaling and adipogenesis. In particular, 
fasting upregulated rate-limiting genes in both the mitochondrial and peroxisomal 
pathways of beta-oxidation. Enhanced fatty acid oxidation in white adipose tissue was 
further suggested by a significant increase in tissue content of the ketone beta-
hydroxybutyrate. Expression profiles suggested that, despite the relatively brief duration 
of feed withdrawal, fasting suppressed adipogenesis; expression of key genes in multiple 
steps of adipogenesis, including lineage commitment from mesenchymal stem cells, were 
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significantly down-regulated in fasted vs. fed adipose tissue. Interestingly, fasting 
increased expression of several inflammatory adipokines and components of the toll-like 
receptor 4 signaling pathway. A second study with Affymetrix microarrays of Fayoumi, 
Leghorn and broiler adipose tissue revealed that genetic leanness shared molecular 
signatures with the effects of fasting. In supervised clustering analysis, fasted broiler 
chickens clustered with lean Fayoumi and Leghorn lines rather than with the fed broiler 
group, suggesting that fasting manipulated expression profiles to resemble those of the 
lean phenotype. 
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                                        CHAPTER I 
LITERATURE REVIEW 
Introduction and Objectives 
The broiler industry has experienced decades of rapid expansion due to 
population growth and the public’s preference for white chicken meat, creating a ~$26 
billion broiler market in 2012 in the United States [1]. Broiler production now exceeds 
that of both beef and pork, and broilers are the most efficient of the major food animals. 
Intensive genetic selection for rapid growth has allowed the broiler industry to keep up 
with the demand. However, it has also resulted in undesirable traits, including an 
increasing fat content. Carcass fat in broilers at market age accounts for 10-15% of the 
total carcass weights [2]. Excess fat is an economic loss to the broiler industry because it 
wastes feed by its conversion to adipose rather than lean tissue and because of costs 
incurred from the need to dispose of fat after processing.  Excess fat may also contribute 
to the development of detrimental traits arising from genetic selection for rapid growth, 
such as reduced fertility and immunocompetence, both of which are seen in obese 
humans [3]. The broiler industry requires new strategies to reduce the fatness in broilers, 
which would economically benefit producers and likely improve health and welfare of 
chickens. Such strategies require the knowledge of adipose tissue metabolism and 
biology, which is still limited in chicken.   
The overall objective of this dissertation was to identify the mechanisms that 
regulate fat deposition in domestic chickens using an approach that couples 
comprehensive transcriptomic and metabolomic methods with system and cellular 
physiology. The objective of study 1 was to characterize the effects of energy restriction 
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and insulin on adipose tissue in broiler chickens. The objective of study 2 was to identify 
functional gene and metabolite classes differentially expressed in adipose tissue of lean 
(Fayoumi and Leghorn) and broiler chickens. The objective of study 3 was to identify the 
similarity between lean chickens and the fasted broilers. The data from study 1 & 2 were 
then integrated together using statistical model to identify the similarity between fasted 
broilers and lean chickens.  
The findings of this work will provide comprehensive information to identify 
potential new targets for genetic selection or management strategies to reduce fat 
accumulation in commercial broilers and to further develop chicken as a model organism 
for studies of human obesity.   
Domestic Chickens 
Domestic chickens originated from their wild ancestor, red jungle fowl, about 
8,000 years ago in Southeast Asia according to the archaeological evidence [4]. Chickens 
exhibited genetic adaptation to a new environment morphologically, physiologically and 
behaviorally during long term domestication [5]. In recent decades, chickens have been 
subjected to human-driven selection mainly for food purposes by laying eggs or 
providing meat, leading to remarkable phenotypic changes.   
Selection driven by the poultry meat and egg industries resulted in a decrease in 
the total number of chicken breeds and produced the breeds that currently dominate the 
world’s poultry industry, especially between 1930 to 1950 [6].  Layers were selected by 
simultaneous improvement of multiple traits, including the age at sexual maturity, 
livability, egg number, shell strength, egg size, and egg weight [7]. Therefore, the 
dominant egg-laying lines used commercially today, including White Leghorns,  Golden 
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Comets and Rhode Island Red,  are characterized by quick maturity, low mortality, small 
body size,  high production of saleable eggs, low feed cost per egg production and 
optimal egg quality. For example, feed conversion of layers has improved from 2.95 to 
2.01 g feed per gram egg, from 1960 to 2001[8], and egg production has increased from 
176 to 309 eggs per hen
 
per year
  
from 1925 to 1998.  
Today’s meat type chickens mostly refer to broilers. Modern broilers with 
superior meat production performance are based heavily on a crossbred of White Cornish, 
New Hampshire and White Plymouth Rock. They exhibit features of fast growth, 
efficient feed conversion and high yield of breast muscle [2]. Their parental lines, White 
Cornish, New Hampshire and White Plymouth Rock, are dual-purpose breeds for both 
egg and meat, and have inferior meat production but better egg production compared to 
broilers.  
The broiler and egg industry has established an efficient and sustainable industry 
by using genetic improvement. The U.S. Department of Agriculture (USDA) has forecast 
that 37.3 billion pounds of broiler meat with the value of $27.7 billion will be produced 
in 2013 according to the USDA Livestock, Dairy and Poultry Outlook. Likewise. total 
egg production will be about 7.5 billion pounds.  
Genetic Selection 
Modern commercial broiler breeding was initially developed in the United States 
as a result of selection for rapid growth. In 1945, the American grocer A&P (Atlantic & 
Pacific Tea Company) organized the national “Chicken of Tomorrow” contests to 
encourage meat-type poultry breeders to develop a more efficient broiler [9]. The genetic 
selection criteria were initially based on the weight and growth rate of birds, which were 
stable and heritable traits and helped improve broiler breeder performance. As feed costs 
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rose, the industry switched the selection criteria to feed efficiency, which helped to 
produce chicks cost effectively.  Genetic selection has greatly improved chicken 
production over the last 50 years and provided high quality dietary protein to humans. 
The market age of today’s broiler is about 6 weeks compared to 12 weeks in 1950s [10]. 
It only needs 3.4 kg of feed in less than 40 days to produce a 2.0 kg broiler today, in 
contrast to 7.2 kg of feed in 95 days to produce a 1.3 kg broiler before genetic selection 
[3].  
However, intensive genetic selection for rapid growth inadvertently selected for 
increased carcass fat. Carcass fat in broilers at market age accounts for 10-15% of the 
total carcass weight and deposits at a rate of  up to six grams fat/kg body wt/day between 
42 and 49 days of age [2, 11, 12]. This is probably because abdominal fat is 
proportionately largest when body weight and growth rate are the critical traits selected, 
since it has a higher heritability than skeleton. Also, the broiler tends to overconsume 
feed, which is another reason for fat deposition in broiler chickens. Excess fat is an 
economic loss to boiler industry by reducing the conversion of feed to meat, and the 
disposal of fat leads to additional economic loss. Excess fat may also contribute to the 
development of other detrimental traits, such as reduced reproductivity and 
immunocompetence, which consequently affect growth and yield of meat [3].  
To solve these problems, broiler breeder management programs developed feed 
restriction methods, i.e., skip-a-day feeding regimen, to manage broiler breeders [13]. In 
this practice, from 21 to 140 days, broiler breeders are fed two’s days’ worth of feed on 
one day and no feed on the next day. In total, the same amount of feed is provided but the 
feed is rapidly consumed, producing a window of fasting. This has proven to be an 
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effective approach to control excess fat deposition in broiler chickens by altering hepatic 
lipogenic gene expression and abdominal fat content [14-17]. However, feed restriction is 
not the ultimate solution, because it is associated with reduced body weight and meat 
production, hunger stress and impaired welfare [18]. Skip-a-day program is practiced 
widely in the USA, but there are some restrictions and regulations already in place to 
limit the application of this program. In particular, its use is banned in some European 
countries, e.g., in the UK. The US is expected to face the challenge to address these 
welfare issues in the coming years.  
Therefore, a successful strategy that can reduce fat deposition without 
compromising lean meat growth is required. Unlike humans, increasing energy 
expenditure by increasing exercise is not an option for chickens. A successful strategy, 
either by genetic selection or by diet and nutrient management, would alter energy 
portioning, preferentially deposit into lean tissue or increase utilization of fat for energy. 
The fact that there are both naturally leaner and fattier lines of chickens among the 
spectrum of common breeds illustrate that there are mechanisms that affect fatness in 
chickens. However, little is known about these mechanisms. Thus, it would be of 
particular interest to understand the cellular and molecular pathways leading to fat loss by 
feed restriction or nutrient deprivation, and to further manipulate the genes associated 
with adiposity in broiler chickens.   
Several genetic lines of fat and lean chickens have been developed through 
different phenotypic selection strategies. These lines have been used to study the 
relationship between lipid metabolism, fatness and rapid growth. The lines selected by 
Siegel for 8-week high and low body weight are representative models to study the 
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correlated traits associated with rapid growth. High body weight chickens showed 
increased feed efficiency, feed consumption, increased carcass fat, increased muscle size 
and number, egg size, but decreased plasma growth hormone, immunocompetence and 
egg production [3].  Lean broiler chickens with reduced abdominal fat and body lipids 
were also obtained through selection on higher feed efficiency (feed consumed/weight 
gain), which confirmed high negative correlation between feed efficiency and fatness 
[19].  
Genetic lines have also been selected for plasma levels of very-low-density 
lipoprotein (VLDL). The high VLDL line of chickens had 38% difference in total lipids 
and 49% more abdominal fat weight, but there were no differences in body weight, food 
intake, hepatic lipogenesis, and lipoprotein lipase (LPL) activity in the high VLDL line 
compared to the low VLDL line [20].  Similarly, selection for low plasma glucose level 
resulted in fat chickens [21]. These studies clearly demonstrated the relationship between 
lipid and carbohydrate metabolism and fatness.  
Direct selection specifically on low abdominal fat content effectively resulted in 
leaner broiler chickens [22]. The fat line chickens that resulted from this selection criteria 
had four times more abdominal fat and 72% more lipids than lean line chickens, but no 
difference in body weight or food intake [22]. Hepatic lipogenesis, VLDL secretion, SCD 
(Δ9-Desaturase) activity, and adipocyte size and number were also higher in fat line 
chickens [23, 24]. Collectively, fat line chickens produced through various genetic 
selection criteria showed common features, including high plasma levels of VLDL, low 
plasma levels of glucose, high hepatic lipogenesis and adipocyte size and number. These 
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results reflected importance of hepatic lipogenesis and glucose consumption in fat 
accumulation.  
Adipose Tissue Biology 
White adipose tissue & brown adipose tissue 
In mammals, there are two major types of adipose tissue: white adipose tissue and 
brown adipose tissue. White adipose tissue, the most common type of adipose tissue, is 
characterized by large lipid droplets in which triglyceride are stored. Brown adipose 
tissue is “brown” because of a high density of mitochondria. The hallmark of brown 
adipose tissue is expression of mitochondrial uncoupling protein-1 (UCP-1), which 
uncouples proton transfer in mitochondria from Adenosine-5'-triphosphate (ATP) 
generation, and the dissipation of energy as heat rather than its storage in ATP. White 
adipose tissue can be further classified as subcutaneous and visceral fat, according to the 
location in the body [25]. Subcutaneous fat is located beneath the skin and visceral fat is 
adipose tissue that lies around the central organs. The predominant site of adipose 
deposition in chickens is abdominal fat and, to a less extent, subcutaneous fat and 
intramuscular fat.  Chickens have relatively low intramuscular fat compared to other 
agricultural animals [26], and no brown adipose tissue, which differs from rodents 
(present throughout life) and humans (present at birth, reduced in adults) [27]. 
Adipogenesis 
White adipose tissue is composed of mature adipocytes and cells of the stromal 
vascular fraction,  including preadipocytes, mesenchymal stem cells (MSC), endothelial 
cells and immune cells, such as T cells and macrophages [28]. Adipocytes arise from 
mesenchymal stem cells (MSC), a multipotent stem cell that has the potential to 
differentiate into adipocytes and other tissues of mesenchymal origin. This is a two-step 
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process: preadipocytes are generated from MSC by lineage commitment and differentiate 
into mature adipocytes through early differentiation and terminal differentiation [29]. 
 This process is orchestrated by a transcriptional cascade involving the peroxisome 
proliferator-activated receptor gamma (PPARγ),CCAAT-enhancer-binding protein alpha 
(C/EBPα) and sterol regulatory element binding protein-1c (SREBP1) [30-32]. PPARγ is 
a member of the nuclear receptor superfamily and is activated by a variety of fatty acids 
and their derivatives, such as prostaglandins. PPARγ participates in adipogenesis through 
binding as obligate heterodimers with retinoic X receptor (RXR). C/EBPα is expressed 
late in adipogenesis and is a key regulator of adipocyte differentiation by regulating 
expression of adipogenic genes. SREBP1 is the transcription factor that is expressed in 
the early stage of adipogenesis and activates PPARγ by secreting lipid molecules that 
bind directly to PPARγ [33, 34].    
The molecular steps of adipogenesis are comparable between chickens and 
humans. Retroviral transfection of C/EBPα, PPARγ and SREBP-1 into chicken embryo 
fibroblasts could induce embryo fibroblasts differentiation into adipocyte-like cells 
associated with lipid droplets accumulation and increased A-FABP [32].  A recent study 
pointed out that fatty acid is essential to induce adipocytes differentiation and identified 
regulatory factors that affect glycerol-3-phosphate dehydrogenase (GPDH) activity,  
intracellular triglyceride accumulation and adipogenesis in chicken, including expression 
of PPARγ and fatty acid-binding protein (aP2)  [35].  
 
 
 
 
    9 
Adipose Tissue Metabolism 
 
Adipose tissue is the major site for energy storage in the form of triglyceride. A 
triglyceride molecule consists of three fatty acids esterified to a glycerol backbone. 
Glycerol is produced from glucose through glycolysis and glyceroneogenesis. In 
mammals, fatty acids can come from diet or be synthesized from glucose in lipogenic 
tissue by catalyzed by fatty acid synthase. Dietary fatty acids are absorbed by enterocytes, 
packaged with cholesterol, lipoproteins and other lipids into chylomicrons, and 
transported into circulation.  Blood-borne chylomicrons are rapidly disassembled, utilized 
or stored in adipose tissue.  Lipids synthesized in the liver are packaged into VLDLs and 
released into the blood directly. TAG-rich VLDL reaching the surface of adipose tissue 
vascular are targets of lipoprotein lipase (LPL) and release fatty acids, which are taken up 
by adipocytes.  
 
In chickens, the contribution of portomicrons (similar to chylomicrons in 
mammals) from dietary fats to triglyceride is low, since there is about 5% of dietary 
lipids in regular feed [36]. Triglyceride (TAG) deposits in chicken adipose tissue 
mainly through the uptake of fatty acids from circulating TAG-rich VLDL delivered 
by the liver. Increased VLDL levels were found in virtually all lines of chickens 
associated with high fatness, reflecting the critical role of the liver in fatness of 
chickens [24]. The contribution of de novo lipogenesis in liver to fat deposition was 
also confirmed using the chicken lines selected by plasma VLDL concentration [20]. 
Low VLDL line chickens were found to be associated with a relative decrease in 
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abdominal fat and total body lipid and lipogenic enzyme activity (FASN, ME, ACL) 
and an increase in body protein [37].    
In the refed state after fasting,  both lean and fat line chickens showed elevated 
plasma VLDL concentration (14-fold and 7-fold, respectively), reaching similar levels 
at last, which indicated that hepatic conversion of glucose to fatty acids is common in 
all lines of chickens, and nutrient status may induce a compensating increase of 
plasma VLDL in lean line chickens Fat line chickens also showed higher hepatic 
VLDL removal rate, other than VLDL secretion [38]. Accordingly, increased 
adipocyte number and size result in higher fatty acid uptake rate in adipose tissue [23]. 
Fat line chickens showed higher LPL activity and its activity was found to be 
positively correlated with fat deposition in broilers [23]. Greater LPL activity per cell 
was observed not only in genetically fat line chickens, but also in broiler chickens 
compared to layers, which exhibited a lower growth rate in both abdominal adipose 
mass and body mass [39].  
De novo lipogenesis  
De novo lipogenesis is an enzymatic pathway that converts acetyl-CoA, the 
intermediate of dietary carbohydrate metabolism, to fatty acids.  There are three types of 
fatty acids based on the number of double bonds, i.e., saturated (SFA, no double bond), 
monounsaturated (MUFA, one double bond) and polyunsaturated fatty acids (PUFA, two 
or more double bonds).  De novo lipogenesis begins with the condensation reaction of 
acetyl-CoA with malony-CoA to produce six-carbon intermediates and proceeds by the 
serial addition of two-carbon units to synthesize 16-carbon palmitate. Palimitate 
undergoes elongation and desaturation (the addition of double bonds) process, leading to 
the formation of various PUFAs.  PUFAs can be classified into two categories, the n-3 
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and n-6 series, depending on the position of the final double bond nearest the terminal 
methyl group. Eicosapentaenoic acid [20:5 (n-3), EPA] and docosahexaenoic 
acid [22:6 (n-3), DHA] are the most common n-3 long-chain PUFAs. They exert 
beneficial functions, i.e., anti-inflammation, anti-obesity and reducing plasma 
triglycerides in humans and rodents.  The general process of de novo lipogenesis is 
shown in Figure 1-1. 
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Figure 1-1. Pathway of fatty acids biosynthesis, elongation and 
desaturation[40] 
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De novo lipogenesis occurs in liver and adipose tissue in a species dependent 
manner. In rodents, adipose tissue accounts for about 50% de novo lipogenesis. Whereas 
in human and chickens, only 15% of de novo lipogenesis occur in adipose tissue, and the 
rest is from liver [41]. The product of de novo lipogenesis in liver are secreted in the form 
of VLDL and delivered to other tissues.  
Acetyl-CoA carboxylase (ACC) is the rate-limiting enzyme catalyzing the 
irreversible carboxylation of acetyl-CoA to produce malonyl-CoA. Two major isoforms 
of ACC, ACACA and ACACB, are predominately expressed in adipose tissue and 
skeletal muscle, respectively. The other critical enzyme is fatty acid synthase (FASN), 
which catalyzes synthesis of palmitate from acetyl-CoA and malonyl-CoA. Fatty acids 
are subsequently esterified with glycerol into triglycerides [42]. Lipogenic enzymes, such 
as FASN, ME, ACC, ATP citrate lyase (ACL) and steroyl CoA (delta 9) desaturase 1 
(SCD1), have relatively low activity in chicken adipose tissue [36, 43]. Expression of 
lipogenic enzyme genes is influenced by Sterol regulatory element binding protein-1 
(SREBP1) [44, 45]. SREBP1 is more expressed in the liver than adipose tissue, which is 
also observed in humans. This may explain the limited de novo lipogenesis in adipose 
tissue of both humans and birds.  
Although de novo lipogenesis in chicken adipose tissue is limited, it is 
regulated by nutritional manipulation. For instance, lipogenesis from acetate was 
inhibited by VLDL as an exogeneous source of fatty acids, which was also observed in 
mammalian adipose tissue [41]. Likewise, de novo lipogenesis may be enhanced when 
excess carbohydrates are consumed.  
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Fatty acid uptake, re-esterification and lipolysis 
Long chain fatty acids translocate across the plasma membrane through 
passive diffusion, and this process is facilitated by membrane associated fatty acid 
transport protein (FATPs, SLC27 family). FATP expression in chicken adipose tissue 
showed an age- and depot-dependent pattern of expression. Expression in the 
abdominal depot increased with age to its highest level at eight weeks of age then 
decreased, whereas in subcutaneous fat, it reached a peak at 12 weeks of age[46]. This 
observation is consistent with the fact that birds are fatter at an older age.   
Fatty acid esterification in adipocytes involves two steps. First, a fatty acid is 
activated to its CoA derivatives; second, fatty acyl-CoA is added to the glycerol 
“backbone” in adipocytes. The two steps are catalyzed by acyl-CoA synthetase (ACS) 
and diacylglycerol acyltransferase 2 (DGAT2), respectively. During this process, 
glycerol-3-phosphate (G3P) is formed by phosphorylation of glycerol or synthesized 
from pyruvate or lactate, which is catalyzed by phosphoenolpyruvate carboxykinase 
(PEPCK). The incorporation of G3P into TAG is catalyzed by glycerol kinase (GK), 
which is considered absent in adipose tissue. However, the mechanism and regulation 
of these processes in chicken adipose tissue remains unknown.  
In mammals, the key enzymes involved in lipolysis of TAG in adipose tissue 
include hormone sensitive lipase (HSL) and adipose triglyeride lipase (ATGL). 
However, the existence of HSL has not been identified in chickens [47]. In 
mammalian adipocytes, HSL was found to form a complex with fatty acid binding 
proteins (FABPs), which indicated the lipolytic effect of FABPs. A-FABP 
overexpression in chicken adipocytes was found to be associated with lipid 
accumulation [48]. Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme in 
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TAG lipolysis, and its expression in chicken abdominal adipose tissue is high. A 
recent study showed that dexamethasone increased ATGL expression through 
activation of glucocorticoid [49], and 24 hours of fasting increased ATGL expression 
at both mRNA and protein levels in broiler adipose tissue [50]. Moreover, ATGL gene 
polymorphisms were associated with chicken growth and fat traits in an SNP 
association study [51]. TAG lipolysis is the procedure that decreases energy storage in 
adipose tissue and may be followed by the increase in fatty acid oxidation, resulting in 
lean muscle growth, which maximizes feed efficiency and is of critical importance in 
animal agriculture. Further studies are needed to explore the mechanism in TAG 
lipolysis, and fatty acid oxidation in chicken adipose tissue. These results indicated a 
relationship between nutritional status and lipid metabolism and adipogenesis.  
Fatty acid oxidation 
Fatty acids can be classified as short-chain (SCFAs, C4–C8), medium-chain 
(MCFAs, C6–C12), long chain fatty acids (LCFA, C10–C16) and very-long-chain fatty 
acids (VLCFAs: C17–C26) based on their length. SCFAs and MCFAs are oxidized 
exclusively in the mitochondria. LCFAs long are oxidized in both the mitochondria and 
the peroxisomes.  Fatty acids longer than 14 carbon atoms are preferentially oxidized in 
the peroxisomes.  
Fatty acids destined for oxidation are first activated and converted to fatty acyl-
CoA by acyl-CoA synthetases long chain family (ACSL) in the cytoplasm, which is 
followed by oxidation in the mitochondria. Fatty acyl-CoA is transported into the 
mitochondria via an acyl-carnitine intermediate, which is generated by carnitine 
palmitoyltransferase 1 (CPT1), the key enzyme catalyzing mitochondria fatty acid 
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oxidation. In humans, three isoforms of CPT1 were identified: CPT1A, mostly express in 
the liver, CPT1B, predominately express in the skeletal muscle, and CPT-1C, exclusively 
express in the brain and testes. On the inner mitochondria membrane, carnitine 
palmitoyltransferase 2 (CPT-2) regenerates fatty acyl-CoA molecules from fatty acyl-
carnitine.  
In contrast to mitochondria, peroxisomes are the site of degradation of VLCFA 
and the synthesis of the important PUFA (DHA and DPA) by shortening C24:6ω3 and 
C24:5ω6, respectively [52]. Peroxisome fatty acid oxidation is initiated by the rate-
limiting enzyme acyl-CoA oxidases (ACOX). This step yields a significant reactive 
oxygen species (ROS) by the reduction of O2 to hydrogen peroxide (H2O2). Among three 
peroxisomal acyl-CoA oxidases, ACOX1 is the most important oxidase that catalyzes the 
oxidation of VLCFA in humans and rodents.   
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Figure 1-2. Mechanism of inhibition of glucose utilization by fatty acid 
oxidation. The extent of inhibition is graded and most severe at the level of pyruvate 
dehydrogenase (PDH) and less severe at the level of 6-phosphofructo-1-kinase (PFK) and 
glucose uptake. PDH inhibition is caused by acetyl-CoA and NADH accumulation 
resulting from fatty acid oxidation, whereas PFK inhbition results from citrate 
accumulation in the cytosol. The mechanism of inhibition of glucose uptake is not clear. 
These effects reroute glucose toward glycogen synthesis and pyruvate to anaplerosis 
and/or gluconeogenesis. See text for further details. CYTO, cytosol; MITO, 
mitochondria , image Image courtesy of Hue, 2009[53]. 
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Glucose and fatty acids are the major fuels for metabolism and there is an 
interaction between their utilization, which is called the glucose-fatty acid cycle.. The 
glucose-fatty acid cycle, also termed Randle cycle [54], describes reciprocal regulation of 
carbohydrate and fat metabolism. i.e., elevation of plasma non-esterified fatty acid 
(NEFA) and fatty acid oxidation inhibit glucose uptake and pyruvate oxidation, and vice 
versa (Figure 1-2). This phenomenon is prevalent in skeletal muscle and adipose tissue.  
As outlined in Figure 1-2, the process is regulated by pyruvate dehydrogenase 
kinase (PDKs). During fatty acid oxidation, activated PDK phosphorylates and inhibit 
pyruvate dehydrogenase (PDH), which in turn inhibits pyruvate oxidation. Fatty acid 
oxidation also leads to elevated NADH, which consequently activate PDKs. Additionally, 
excess acetyl-CoA serves as the substrate for citrate or acetyl-carnitine in the cytosol. The 
resultant citrate is an allosteric inhibitor of PFK1 and consequently inhibits glycolysis.  
Regulation of Adipose Metabolism 
Among the hormones, insulin is studied most often as a regulator of adipose 
metabolism due to its important roles in glucose and lipid metabolism. In mammals, 
insulin promotes glucose utilization by stimulating glucose transport and inhibiting 
lipolysis (Figure 1-3B). The transport of glucose from the plasma membrane to peripheral 
tissues is mediated by glucose transporter proteins (GLUT), specifically GLUT4, the 
insulin-responsive glucose transporter highly expressed in muscle and adipose tissue in 
rodents [55, 56].   
Chickens, however, are considered to be refractory to insulin. Chicken is 
characterized by the unique features of hyperglycemia and insulin resistance. Chickens 
have a high plasma glucose level of 2 g/l in the fed state under normal insulin 
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concentration in circulation [57]. This level would be considered diabetic in human. The 
injection of insulin cause slight hypoglycemia in chickens, but the doses are higher than 
those required in mammals [57], which indicates the insensitivity of chickens to insulin. 
However, insulin does play a role in  glucose homeostasis in chickens, which was 
demonstrated by the evidence that immuno-neutralization of insulin largely enhanced 
plasma glucose in fed broilers [58]. However, the association of glycemia with adiposity 
of chickens differ from that of mammals in that lower fasting plasma glucose levels are 
found in fatter chickens [59, 60]. In chicken adipocytes, insulin was found to increase 
glucose uptake, glucose oxidation, and lipogenesis [61]. However, the effect of insulin on 
adipocytes was thought to be limited compared to the effect of other hormones, such as 
glucagon [57].  
Not all of the isoforms of glucose transporters in chickens have been identified. 
The known isoforms expressed in chickens include GLUT1, which is highest  
expressed  in the brain and adipose tissue, GLUT2, which is only expressed in liver 
and kidney, GLUT3, which is  highly expressed in  brain, and GLUT8, which is highly 
expressed in kidney and adipose tissue  [55]. Chicks injected with insulin exhibited a 
significant increase in glucose uptake in cardiac tissue, brain, kidney, and skeletal 
muscle, but not in cardiac muscle and adipose tissue. This finding suggested that 
adipose tissue may be excluded from the insulin-responsive glucose transport 
mechanism [62]. This is not surprising because acetate and pyruvate, rather than 
glucose, are the major substrates for de novo lipogenesis to produce TAG in chickens, 
and glucose is only the precursor for glyceride-glycerol. Insulin actually affects 
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lipogenesis by stimulating the incorporation of acetate into lipids, which was observed 
in isolated chicken adipocytes [63].  
To further understand the mechanism of the regulatory roles of insulin in 
chickens, several chicken models were generated by manipulating diet or insulin 
deprivation to characterize insulin receptors (IR), as well as other components of the 
insulin signaling pathways. These studies revealed that different chicken tissues have 
specific responses to insulin. All of these studies proved that the liver is sensitive to 
insulinemia in both early steps (IRß, IRS-1, Shc and PI3K) and downstream elements 
(Akt, MAPK ERK2, GSK3, P70S6K and S6 ribosomal protein) of insulin signaling 
[64-66]. In contrast, muscle showed insulin resistance, but only in the early steps of 
insulin signaling [58, 67],  whereas adipose tissue was more refractory to insulin than 
muscles in both the early steps and downstream elements of insulin signaling cascades 
[68]. Moreover, genetically fat and lean line chickens showed apparent differences in 
insulin signaling in response to feeding, prolonged fasting and refeeding. Fat line 
chickens exhibited higher insulin sensitivity in liver than lean line chickens in terms of 
early steps (IRß, IRS-1, Shc and PI3K) of insulin signaling cascade, which would 
account for increased liver lipogenesis in fat line chicken [64]. Nevertheless, little 
difference was observed in leg muscle of fat line chickens regarding the early steps of 
insulin signaling in response to nutritional status, which may be due to consistent 
refractory to insulin in muscles [64].  
Glucagon is a major lipolytic hormone in chickens [69]. Glucagon binds to 
receptors on the surface of adipocytes and catalyzes the production of cyclic AMP 
(cAMP) inside the adipocyte [70]. As in mammals, induction of cAMP mediates the 
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lipolytic effect of glucagon by activating lipase enzymes. Glucagon-induced cAMP was 
much higher in chicken adipocyte than in rat adipocyte; this is probably due to the 
variations in the degradation rate of cAMP [71], which may explain the powerful effect 
of glucagon in chickens., Other hormones exhibited different effects on chickens. For 
instance, growth hormone has both lipolytic and anti-lipogenic effects  [72]. Further 
studies are needed to elucidate the effects of thyroid hormones (T3 and T4) and insulin 
growth factors on adipose physiology and metabolism.  
In addition to glucagon, other lipolytic stimuli include catecholamine (i.e., 
epinephrine, norepinephrine and dopamine), melanocortins  (i.e., Adrenocorticotrophin 
hormone (ACTH) and melanocytestimulating hormone (MSH)), thyroid-stimulating 
hormone (TSH) and adenosine [73]. The main pathway leading to lipolysis is the cAMP-
dependent protein kinase (PKA) pathway (Figure 1-3A).  Through this pathway, 
stimulating G protein coupled receptors (GPCRs) and activating downstream signaling 
factors like the enzyme adenylyl cyclase lead to increased synthesis of cyclic-AMP 
(cAMP) from ATP. Increased level of cAMP subsequently activate PKA, resulting in 
lipolysis [74].  Activation of protein kinase C and stimulation of the mitogen activated 
protein kinase (MAPK) pathway could also increase lipolytic activity in adipocytes [75]. 
A recent study found that lipolysis stimulated by β-adrenergic receptor activation, 
increasing cAMP levels in white adipocytes of rodents, acutely induces mitochondrial 
uncoupling. This process may also contribute to fatty acid oxidation. The effect was 
amplified in the absence of which are amplified in the absence of scavenging BSA [76].  
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Figure 1-3. Regulation of lipolysis in adipocytes. (A) Desnutrin/ATGL 
initiates lipolysis by hydrolyzing triacylglycerol (TAG) to diacylglycerol (DAG). 
During fasting, catecholamines, by binding to Gαs-coupled β-adrenergic receptors (β-
AR), activate adenylate cyclase (AC) to increase cAMP and activate protein kinase A 
(PKA). PKA phosphorylates HSL, resulting in translocation of HSL from the cytosol 
to the lipid droplet. PKA also phosphorylates the lipid droplet associated protein 
perilipin. (B) In the fed state, insulin binding to the insulin receptor (IR), results in 
decreased cAMP levels and decreased lipolysis. Insulin also suppresses expression of 
desnutrin/ATGL. Image courtesy of Ahmadian, 2010 [74]. 
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Because lipid metabolism pathways and adipose physiology are highly 
conserved in chickens, hormonal and nutritional regulation of hepatic lipogenesis, 
adipose fatty acid uptake and the whole process of adipogenesis are comparable 
between chickens and humans. Understanding the mechanisms of hormonal regulation 
may also be beneficial in developing new therapies for human obesity. 
Mechanisms of Adipose Tissue Expansion  
Adipose tissue expands with plasticity to increase TAG uptake and 
accommodate lipids that would otherwise be deposited ectopically in tissues not 
intended to store significant amounts of lipid. Adipose tissue can expand its storage 
capacity by either enlargement of existing adipocytes (hypertrophy) or formation of 
new adipocytes (hyperplasia). Adipose expansion also requires increasing the local 
vascular supply, and coordinating different cell types, including endothelial precursor 
cells, immune cells, and preadipocytes. In humans,  adult-onset obesity is associated 
with hypertrophy, whereas early-onset obesity in children arises from both adipocyte 
hypertrophy and hyperplasia [27]. The development of hyperplasia is regulated by the 
growth factors regulating preadipocyte commitment, such as preadipocyte factor-1 
(Pref-1, DLK1, SCP-1). Pref1 was found to promote muscle development and inhibit 
adipose development in mice and play an important role in the regulation of skeletal 
stem cell differentiation in humans [77].  
Adipose cellular development in chicken is characterized by hyperplasia early 
in life through posthatching to first several weeks of age [78] and it is paralleled by 
hypertrophy through adulthood. Genetically fat line and lean line chickens show great 
divergence in both adipocyte size and number, despite a similar feed intake and body 
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weight [79]. Adipocyte number was two- fold higher in the fat line chickens compared 
to the lean line chickens at 2 and 5 week of age [23]. Consequently, cell hyperplasia 
led to high LPL activity in adipose tissue of genetically fat line chickens and enhanced 
fatty acid uptake in 2-week old fat line chickens [23]. Hypertrophy predominates at 
older ages, e.g., 12-14 weeks [41]. Therefore, hyperplasia is responsible for early 
development of fat deposition, which may exacerbate adult obesity. This correlates 
with the observations in humans that adult-onset obesity is associated with increased 
adipocyte size, whereas early-onset obesity has both adipocyte hypertrophy and 
hyperplasia [80]. Adipocyte hypertrophy was considered to be more correlated with 
excessive fat deposition and more likely to explain the variation of fatness among lines 
than hyperplasia [81]. Previous studies also illustrated that the difference in plasma 
triglyceride and phospholipids between fat and lean lines was not significant after nine 
weeks of age [22], as well as de novo fatty acid synthesis in 15-week-old chickens 
[82], but the difference in abdominal fat was still pronounced. This finding indicated 
that adipocyte hypertrophy and adipose expansion are probably responsible for the 
majority of differences in fatness of fat line and lean line chickens during adulthood.  
In chicken adipose tissue, full length DLK1 gene also had a myogenic function 
and had higher expression in preadipocytes than adipocytes in an age dependent 
manner [83]. Likewise, some growth factors regulate preadipocyte proliferation and 
differentiation, such as transforming growth factor-ß (TGFß), insulin-like growth 
factors (IGFs) and fibroblast growth factors (FGF). TGFß also has functions to 
promote proliferation and inhibit differentiation of adipocytes precursors, which was 
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also observed in chickens [84, 85]. TGFß also reduces LPL activity in accordance with 
its anti-lipogenic activity.  
A recent study reported the onset of adipocyte hypertrophy as early as five 
weeks of age in fat line chickens resulting from the sustained selection pressure on the 
fatness trait. And it also demonstrated that the divergence of adipocyte cell number 
between the two lines was pronounced from 10 days of age, which indicated ontogenic 
variation in chicken adipose tissue due to genetic selection [86].  
Endocrine Functions of Adipose Tissue 
Adipokines 
In addition to its classical role as an energy storage depot,  white adipose tissue 
is now recognized as an important endocrine organ due to its ability to synthesize and 
secret a number of proteins that are collectively referred as adipokines [87]. The term 
“adipokines” is defined from “adipose cytokine” because many of adipokines are 
cytokines with known roles in immune functions [88]. Obesity is associated with 
differentially expression of many adipokines. In general, inflammatory adipkines such 
as TNFa and IL-6 are at higher levels in obese vs. lean adipose tissues.  Adipokines 
are considered as the molecular link between inflammation, obesity, insulin resistance 
and other metabolic syndromes in humans [89, 90].  Some adipokines, such as leptin, 
adiponectin, resistin and visfatin, are involved in energy and glucose homeostasis.  
Adipokines exhibit pro-inflammatory and/or anti-inflammatory effects. For 
example, chemokines such as monocyte chemotactic protein 1 (MCP-1) and 
interleukin 8 (IL-8), IL-6, IL-1, angiotensin-II (Ang II) and tumor necrosis factor a 
(TNF-a), have been implicated to be responsible for the development of insulin 
resistance and the increased risk of cardiovascular disease associated with obesity. By 
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contrast, induction of anti-inflammatory adipokines, such as IL-10 and adiponectin, 
inhibit IL-6 and nuclear factor κB (NF-kB) and lead to increased insulin sensitivity 
and elevated fatty acid oxidation [91].  
The relationship between adipokines and obesity has been intensively studied 
in many other species, including dogs, cats and horses [88], but the relationship in 
chickens remains unknown. For example, the existence of chicken leptin remains 
debated [92-94], although leptin receptor (LEPR) has been identified in multiple 
chicken tissues, including adipose tissue [95-98]. Similarly, TNFa, resistin and 
omentin, which are extensively studied in mammals, have not been identified in 
chickens. The expression of adiponectin and visfatin in chicken adipose tissues has 
been confirmed. Adiponectin is an anti-inflammatory adipokine that enhances insulin 
sensitivity and is regulated by C/EBPα in humans [99]. Adiponectin gene expression 
in abdominal adipose tissue in broilers was increased with restricted dietary energy 
and protein levels, although only at a younger age  [100], which was also seen in 
humans with low-calorie diet [101]. Visfatin was found associated with obesity [12] 
and type 2 diabetes mellitus [102] through mediating insulin secretion in pancreatic 
βcells [103]. In chickens, visfatin expression, especially in adipose tissue, was 
regulated by the factors related to energy homeostasis in a tissue-specific and sex-
dependent manner [104].  Therefore, their regulation in adipose tissue of chicken are 
still of interest.  
Adipose tissue expansion is also associated with immune cells infiltration.  A 
number of immune cells reside in adipose tissue, including macrophages, mast cells, B-2 
cells, CD8+ T cells, IFN-γ+ CD4+ T cells, eosinophils, and regulatory T cells. They exert 
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a wide range of functions, which can be detrimental by inducing inflammation and 
insulin resistance or be beneficial by protecting against these pathologies [28]. These 
immune cells secrete mediators such as IL-6, TNFa, and MCP1 involved in immune 
responses. In lean individuals, adipocytes interact with anti-inflammatory immune cells, 
such as eosinophils and regulatory T-lymphocytes (Treg). However, in obese individuals, 
obesity drives the interaction with inflammatory immune cells and stimulates the 
infiltration macrophages (Figure 1-4).   
Macrophages that infiltrate adipose tissue contribute to the increased expression 
of inflammatory cytokines in obesity in human and rodents [105]. Adipose tissue 
macrophages are classified into M1 phenotype which secretes high level of pro-
inflammatory cytokines, such as IL-6 and TNF-α, and M2 phenotype which mainly 
secretes anti-inflammatory cytokines, such as IL-10. Adipose tissue from obese animals 
give rise to the M1 phenotype by expressing high levels of chemokines, i.e., MCP-1, or 
stimulated by TLR4 ligands, i.e., saturated fatty acids. In contrast,  macrophages maintain 
the M2 phenotype in lean adipose tissue [105]. Little is known about the presence, 
recruitment or types of macrophages in chicken adipose tissue. It was found that 
lipogenesis in chicken adipocytes, rather than  hepatocytes, was increased by conditioned 
medium from chicken macrophages [106], which suggest a role for macrophage 
infiltration in chicken adipose accumulation.  
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Figure 1-4. Schematic representation of adipocyte–immune-cell interactions and the 
soluble mediators involved in adipose tissue of lean versus obese individuals. Image 
courtesy of Schipper, 2012 [28]. 
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Genetic Mapping of Fatness-synteny with Human Genetic 
Studies of Obesity 
For decades, quantative trait loci (QTL) have been used to identify the genes 
that affect disease resistance and productivity using different types of genetic crosses. 
For this reason, a dense linkage map has been produced to enrich genetic resources. 
The availability of genomic and genetic resources, including the genome sequence, the 
high-density linkage map, and the newly developed web-based tool Chicken Obesity 
Gene Map in Gallus Gbrowse, enable large scale analyses of gene function using 
chickens as an animal model for human research. Linkage mapping suggest that the 
chicken genome has a better synteny with the human genome than the mouse genome; 
there are around 100 conserved synergic groups between chicken and human, which in 
mouse and human are 167 [107].   
Chicken F2 populations generated from chickens divergently selected for low or 
high growth rate and abdominal fatness provide valuable models through which to 
integrate phenotypes with genotypes. Genome-wide linkage analyses on F2 populations 
have identified QTLs associated with body composition, growth and metabolic traits 
[108-110]. Additionally, F2 populations generated from fast-growing broilers male line 
and 2 slow-growing inbred lines (Leghorn and Fayoumi) of chicken populations provide 
comparative models to study growth and fat deposition in chickens. Genome-wide studies 
on these F2 chickens have identified QTLs associated with abdominal fat percentage, 
growth and average daily gain, body composition, skeletal integrity and metabolic traits 
in the chickens [111-114].   
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These studies found that adiposity in chickens is polygenic and under the 
control of multiple chromosomal loci, which have high synteny with human obesity. 
Most of the genes located on QTL regions for the fatness trait were found to be 
obesity and diabetes related genes in humans [115-117]. For example, QTL mapping 
of metabolic and body composition traits in F2 intercross between high-growth and 
low-growth chicken lines revealed that QTL for fatness and plasma glucose are co-
localized on several loci, which control each trait in the same direction [115]. This 
finding fits with the metabolic deviations observed in obese humans with 
hyperglycemia [115]. Furthermore, GLUT12 gene, which was found associated with 
hypertension and diabetic nephropathy in mammals, was targeted for plasma glucose 
level by QTL analysis. Additionally, PPARγ, one example of the common genes 
mapped with human obesity, was identified to be associated with plasma glucose and 
NEFA in this study [115, 117]. Such comparative studies provide unique opportunities 
for fully exploring the genetic causes of obesity and T2D in humans.  
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CHAPTER II 
TRANSCRIPTOMIC AND METABOLOMIC PROFILING 
OF CHICKEN ADIPOSE TISSUE IN RESPONSE TO 
INSULIN NEUTRALIZATION AND FASTING 
 
This chapter is adapted from the following publication: 
Bo Ji, Ben Ernest, Jessica R Gooding, Suchita Das, Arnold M Saxton, Jean Simon, Joelle 
Dupont, Sonia Métayer-Coustard, Shawn R Campagna,  and Brynn H Voy. 
BMC Genomics  2012 13:441. 
 
Abstract 
Domestic broiler chickens rapidly accumulate adipose tissue due to intensive 
genetic selection for rapid growth and are naturally hyperglycemic and insulin resistant, 
making them an attractive addition to the suite of rodent models used for studies of 
obesity and type 2 diabetes in humans. Furthermore, chicken adipose tissue is considered 
as poorly sensitive to insulin and lipolysis is under glucagon control. Excessive fat 
accumulation is also an economic and environmental concern for the broiler industry due 
to the loss of feed efficiency and excessive nitrogen wasting, as well as a negative trait 
for consumers who are increasingly conscious of dietary fat intake. Understanding the 
control of avian adipose tissue metabolism would both enhance the utility of chicken as a 
model organism for human obesity and insulin resistance and highlight new approaches 
to reduce fat deposition in commercial chickens. We combined transcriptomics and 
metabolomics to characterize the response of chicken adipose tissue to two energy 
manipulations, fasting and insulin deprivation in the fed state. Sixteen to 17 day-old 
    32 
commercial broiler chickens (ISA915) were fed ad libitum, fasted for five hours, or fed 
but deprived of insulin by injections of anti-insulin serum. Pair-wise contrasts of 
expression data identified a total of 2016 genes that were differentially expressed after 
correction for multiple testing, with the vast majority of differences due to fasting (1780 
genes). Gene Ontology and KEGG pathway analyses indicated that a short term fast 
impacted expression of genes in a broad selection of pathways related to metabolism, 
signaling and adipogenesis. The effects of insulin neutralization largely overlapped with 
the response to fasting, but with more modest effects on adipose tissue metabolism. 
Tissue metabolomics indicated unique effects of insulin on amino acid metabolism. 
Collectively, these data provide a foundation for further study into the molecular basis for 
adipose expansion in commercial poultry and identify potential pathways through which 
fat accretion may be attenuated in the future through genetic selection or management 
practices. They also highlight chicken as a useful model organism in which to study the 
dynamic relationship between food intake, metabolism, and adipose tissue biology 
Introduction 
The domestic chicken provides a widespread and relatively inexpensive source of 
dietary protein for humans. In addition to its role as a food animal, the chicken has a long 
history as a valuable model research organism [118]. These dual considerations led to the 
selection of chicken as the first agricultural animal model to be sequenced at the genome 
level [119]. While chickens have been used heavily for studies of developmental biology 
and immunology, a number of traits make them a viable model for studies of adipose 
biology, obesity and insulin resistance. Commercial broiler chickens, in particular, 
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rapidly accumulate excess adipose tissue as a result of genetic selection for growth and 
are considered “obese” relative to leaner egg-laying or wild strains of chickens (rev. in 
[120]). Chickens mimic the early stage of type 2 diabetes in humans, exhibiting both 
hyperglycemia (up to 200 mg/dL in the fasting state) and resistance to exogenous insulin 
[121, 122]. Like humans, but unlike rodents or pigs, chickens rely on liver rather than 
adipose tissue for the majority of de novo lipid synthesis [123-125]. Most metabolic 
genes are conserved with humans, and a number of the quantitative trait loci (QTLs) that 
have been linked to fatness in chickens contain genes implicated in human susceptibility 
to obesity or diabetes [126]. Chickens also represent a model for studying mechanisms of 
adipocyte hyperplasia during development, a process that may exacerbate adult obesity. 
During at least the first several weeks after hatch, chicken adipose tissue expands more 
through adipocyte hyperplasia than hypertrophy, and an early increase in adipocyte 
number is a common feature of some lines genetically selected for excess adiposity [11, 
127]. Finally, the egg presents opportunities to directly manipulate the developmental 
milieu and study the consequences on adipose metabolism via in ovo injection. 
Relatively little is known about regulation of adipose tissue deposition and 
metabolism in chicken. Because of its relative importance in lipogenesis, most studies 
have focused on the role of liver in adipose expansion. Several genetic lines of fat and 
lean chickens have been developed through phenotypic selection, most of which have 
both elevated plasma levels of VLDL and lower levels of plasma glucose, reflecting the 
importance of hepatic lipogenesis and glucose consumption in fat accretion. Reciprocally, 
phenotypic selection for low plasma glucose simultaneously selects for fatness [128]. 
Both chicken and mammalian adipocytes develop through a sequence of molecular 
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triggers including activation of CEBPα and PPARγ [129]. A clear point of divergence, 
however, is their responsiveness to insulin. Unlike in mammals, insulin has minimal 
effect on glucose uptake in chicken adipose tissue [62]. In fact, an avian homolog of the 
insulin-sensitive glucose transporter GLUT4 has not been identified in the current 
chicken genome database. Insulin does, however, stimulate uptake of acetate, which is 
the preferred substrate for de novo lipogenesis in chicken adipocytes, although the 
magnitude of the effect is relatively modest [130]. Insulin signaling appears to proceed 
through tissue specific cascades in chicken metabolic tissues. In liver, insulin elicits a 
signaling cascade that parallels the response in mammals, including tyrosine 
phosphorylation of insulin receptor β-subunit (IRβ), insulin receptor substrate-1 (IRS-1) 
and Src homology 2 domain-containing substrate (Shc) and activation of 
phosphatidylinositol 3-kinase (PI3K) [65, 131]. The situation in skeletal muscle is more 
complex. Tyrosine phosphorylation of IRβ and IRS-1 and PI3K activity are not regulated 
by insulin, whereas events downstream of PI3K (e.g. Akt and P70S6K activation) are 
accordingly sensitive [58]. We recently reported that insulin also does not elicit a 
classical IRβinitiated cascade in chicken adipose tissue, including the downstream steps 
of Akt and P70S6K activation [132]. Insulin also does not inhibit lipolysis in chicken 
adipose tissue; glucagon, is the primary lipolytic hormone (rev. in [133]). 
In the present study we simultaneously characterized the effects of a short term (5 
hours) fast or neutralization of insulin action (5 hours) on adipose tissue of young (16–17 
day-old), fed commercial broiler chickens. The goals of this study were two-fold. First, 
we sought to identify pathways activated by feed restriction, reasoning that they may 
highlight potential strategies for control of fatness through either genetic selection or 
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improved management practices. Simultaneously, we sought to understand the 
contribution of insulin, if any, into chicken adipose physiology. No experimental model 
of diabetes exist in chicken: total pancreatectomies are not achievable, and alloxan and 
streptozotocin are inefficient at destroying pancreatic chicken beta-cells (rev. in [122]). 
The two treatments were compared to distinguish potential insulin-specific changes from 
those that could be mimicked by fasting through changes in nutrient availability. Both 
treatments were shown previously to elicit significant alterations in several plasma 
metabolic and endocrine parameters [58]; in the studies reported herein, samples of 
abdominal adipose tissue were issued from the same experiment. Tissue metabolomics 
was combined with microarrays to bridge the gap between gene expression, metabolic 
and physiological responses, and to identify the composite effects of both fasting and 
insulin deprivation on chicken adipose tissue. 
Materials and Methods 
Animals 
Male broiler chicks (ISA 915, Institut de Se l´ection Animale, Saint Brieuc, France) 
from which samples were collected for this study were hatched and raised under standard 
conditions, as originally described by Dupont [58] and in accordance with the guidelines 
for Care and Use of Agricultural Animals in Agricultural Research and Teaching. Briefly, 
at 16–17 days of age, chicks of similar body weights were either allowed to continue 
feeding (ad libitum fed controls), fasted for five hours, or fed but injected at 0, 2 and 4 
hours with porcine anti-insulin serum (insulin neutralized). Both the fed and fasted 
groups received injections of normal porcine serum as a vehicle control. Abdominal 
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adipose tissue samples were harvested and rapidly snap-frozen in liquid nitrogen, 
pulverized, then stored at 
-
80°C until analysis. Adipose samples from five birds in each 
group were used for both microarray and metabolomic analyses. 
Gene expression 
Total RNA was isolated from chicken adipose samples using the RNeasy Lipid kit 
and incorporating an on-column DNase treated with the RNase-free DNase Set according 
to the manufacturer's protocol (Qiagen.com). RNA quality and concentration were 
measured using the Experion System (Bio-Rad.com); only RNA passing recommended 
standards of quality was used for further studies. Transcriptome profiling was performed 
by Genome Quebec (Montreal, Canada) using the Affymetrix GeneChip Chicken 
Genome Array (San Diego, CA). Microarray data from this study are deposited in the 
Gene Expression Omnibus (GEO) under the accession number GSE35581. For real time 
RT-PCR validation, cDNA was synthesized using the iScript cDNA Synthesis kit (Bio-
Rad.com). Commercially designed and validated primer sets (QuantiTect) and the 
associated SYBR Green master mix (Qiagen.com) were used to assay gene expression on 
a CFX96 real-time PCR detection system (Bio-Rad.com). All samples were analyzed in 
triplicate and normalized to ß-tubulin. Relative differences in gene expression were 
determined using the 2
-ΔΔCT
 method and statistical differences were tested by analysis of 
variance (ANOVA) [134]. 
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LC-MS/MS 
Abdominal adipose tissue samples from five birds in each treatment group (the 
same five birds used for expression profiling) were extracted by placing tissue in a mortar 
containing liquid nitrogen and then powdering with a pestle. Portions (8–40 mg) of the 
powered tissue were weighed into 1.5 mL centrifuge tubes. Chilled methanol (0.5 mL at 
−80°C) and internal standard (5 μL of 1.7 mM benzoic acid in negative mode or 4.25 mM 
tris(hydroxymethyl)aminomethane in positive mode) were added to each tube. Each tube 
was mixed thoroughly by vortexing for two minutes, and the metabolites were extracted 
from the tissue for 30 min at 4°C. The tubes were then centrifuged (5 min, 4°C, 16.1 rcf) 
and supernatant (210 μL) was split into two autosampler vials. One of these samples was 
immediately placed on the LC-MS/MS for analysis, while the other was stored at −80°C 
for analysis in the opposite polarity ion mode on the following day. 
Samples were placed in an autosampler tray chilled to 4°C, and 10 μL of each was 
injected onto an LC column for analysis. The chromatography method for positive ion 
mode was reported previously by Bajad and coworkers [135], with one exception that the 
column was cooled to 10°C. The chromatography method for negative ion mode was 
performed as reported by Waters and coworkers [136], except the gradient was allowed 
to run 50 min instead of 45 min to allow more thorough equilibration of the column. The 
eluent was introduced directly into the MS via an electrospray ionization (ESI) source 
fitted to a Finnigan TSQ Quantum Discovery Max triple quadrupole MS (Thermo 
Electron, Waltham, MA) through a 0.1 mm internal diameter fused silica capillary. The 
spray voltage was 4500 V in positive mode or 3000 V in negative mode. The sheath gas 
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(nitrogen) was set to 40 psi, and the capillary temperature was set to 290°C. The collision 
cell gas (argon) was set to a pressure of 1.5 mTorr. Samples were analyzed using selected 
reaction monitoring (SRM) mode with a scan width of 1 m/z and a scan time of 0.05 s. 
The SRM parameters for most metabolites have been published previously [135]. This 
method was used to scan for almost 300 metabolites. Xcalibur software (Thermo 
Scientific, Waltham, MA) was used to manually assess the elution time of the correct LC 
spectral peak for each metabolite-specific SRM. The Quan Browser utility in Xcalibur 
was then used to integrate the LC spectral peak area (in ion counts) for each detected 
compound, and these data were exported to a Microsoft Excel spreadsheet for further 
processing. 
Statistical analysis 
Statistical analysis of the microarray data was performed using R 2.9.0 and 
routines contained in Bioconductor (bioconductor.org). GC robust multi-array average 
(GCRMA) was used to normalize and scale the raw data from CEL files. The normalized 
data were filtered for low expression by removing any probes with normalized expression 
less than 3 in at least 5 arrays. Statistical significance of gene expression differences were 
analyzed by one-way ANOVA and empirical bayes using the limma package. Differential 
expression was defined based on false discovery rate (FDR) adjusted p-value <0.05 [137]. 
Venn diagrams of differentially expressed genes were plotted to visualize the number of 
differentially expressed genes for each treatment comparison and their intersections. 
Hierarchical clustering of significant genes was performed using the hclust function and a 
hierarchical clustering heatmap was created using heatmap.2 in the gplots package. 
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Hierarchical clustering also was used to identify correlated patterns of gene expression 
and metabolites. The Database for Annotation, Visualization and Integrated Discovery 
(DAVID, version 6.7) and ClueGO, a Cytoscape plug-in, were used for Gene Ontology 
(GO) at level 6 and 7 and KEGG analysis of differentially expressed genes [138, 139]. 
Statistical analysis of metabolomic data was performed using an analysis tool that we 
developed specifically for metabolomic data analyses [140]. The script (metabR), written 
in the language R, uses linear mixed-effect modeling to normalize metabolomics data 
containing both fixed- and random-effect confounding variables. The script averages any 
replicate measurements (statistical sampling) made on experimental units and performs 
ANOVA to test for statistical differences between experimental groups. 
Results  
Expression levels of a total of 2016 genes were significantly altered by fasting 
and/or insulin neutralization when compared to fed controls based on an FDR adjusted p-
value < 0.05 (Additional file 1; Figure 2-1A). Sixty-nine percent of these genes showed a 
fold-change ≥ |1.5| (Figure 2-1B). The majority of changes in expression were attributable 
to fasting, with 917 up-regulated and 863 down-regulated genes in fasted vs. fed adipose 
tissue. Insulin neutralization altered expression of 92 genes, 72 of which were also 
differentially expressed with fasting (Figure 2-1A). All genes that were affected by both 
treatments changed in the same direction (i.e., up- or down-regulated in both groups). 
Real-time RT-PCR was employed to validate differential expression based on the 
microarray data. Eleven genes were selected based on fold-change or biological functions 
of interest (Table 2-1). Differential expression under fasting versus fed conditions was 
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validated for all genes except pre-B-cell leukemia homeobox 3 (PBX3). Ten of the eleven 
genes were also differentially expressed in insulin neutralized compared to fed birds 
based on QPCR. 
Genes that were differentially expressed in at least one pairwise comparison were 
clustered to visualize the similarities between groups and to determine if insulin-
neutralized expression profiles were more similar to fasted or to fed status. As shown in 
Figure 2-2A, samples within each of the three experimental groups clustered together. 
The dendrogram also showed that the fasting group was distant from fed and insulin-
neutralized groups, which were closer to each other. To further visualize relationships 
between treatments with regard to gene expression, distinct clusters of genes were 
extracted and submitted to gene set enrichment analysis to identify GO terms and 
pathways that were significantly overrepresented among genes contained in these clusters. 
Seven clusters represented four general patterns of similarities between treatments 
(Figure 2-2B). Clusters 1, 3 and 4 consisted of genes with higher expression in fasting 
compared to both insulin-neutralized and fed conditions, with insulin-neutralized 
intermediate between fasted and fed. This set of genes was significantly enriched in GO 
terms related to protein and lipid catabolism and to cell signaling, including regulation of 
the stress-sensitive NFκB cascade (Table 2-2). These three clusters were also enriched in 
members of the KEGG pathways ubiquitin mediated proteolysis, sphingolipid 
metabolism, PPAR signaling, fatty acid metabolism and the peroxisome. The rate-
limiting genes for fatty acid oxidation (ACOX1 and CPT1A), along with fatty acid 
binding proteins 5 and 6, are contained in these three clusters. Clusters 5 and 7 also 
contained genes with higher levels in fasted vs. the other two groups, but with 
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comparable expression levels between insulin-neutralized and fed, and thus no clear 
effect of insulin loss.  
These two clusters were significantly enriched in pathways related to signaling 
and metabolism, including enzyme linked receptor protein signaling pathway (p = 0.0097) 
and in the KEGG pathways for glycerolipid metabolism and PPAR. Genes responsible 
for the latter enrichment include PPARΔ, which was recently shown to increase total 
oxidative metabolism in white adipose tissue [141]. Clusters 2 and 6 contained genes 
expressed at lowest levels in fasted chickens. Genes in cluster 2 were expressed at 
intermediate levels in the insulin-neutralized group relative to fed and fasted. This set of 
genes was significantly enriched in GO annotations related to monosaccharide catabolic 
process and glucose metabolism, and in genes comprising the KEGG pathways for 
carbohydrate metabolism, TCA cycle and glycolysis (Table 3-2). Finally, cluster 6 
consisted of genes that were also lowest in fasting but showed no clear effect of insulin 
loss, with similar expression in fed and insulin-neutralized groups. This set of genes was 
significantly enriched for the KEGG pathways steroid biosynthesis (p = 0.0043), 
glyoxylate and dicarboxylate metabolism (P = 0.012) and pyruvate metabolism 
(P = 0.033), along with a number of genes involved in lipid biosynthesis, which was the 
highest scoring GO category (p = 0.6). Cluster 8 was a distinct, small cluster with variable 
expression within group and no significant GO or KEGG annotations. 
Global biological responses to fasting and to insulin neutralization were further 
characterized using KEGG pathway matching, based on genes with statistically 
significant differential expression (FDR < 0.05) and absolute fold-change ≥1.5. Genes 
    42 
altered exclusively by fasting represented a wide range of cellular pathways, indicating 
significant effects of even a five hour fast on adipose function and metabolism in chicken. 
Fasting exerted significant effects on pathways related to carbohydrate, amino acid and 
lipid metabolism and synthesis. Within the categories related to lipid metabolism, fasting 
up-regulated expression of genes involved in fatty acid oxidation (e.g., acyl-CoA oxidase 
1 (ACOX1), acetyl-CoA carboxylase beta (ACACB), carnitine palmitoyltransferase 1A 
(CPT1A)) and down-regulated expression of genes that control fatty acid, cholesterol and 
triacylglycerol synthesis (e.g., 1-acylglycerol-3-phosphate O-acyltransferase 9 
(AGPAT9), ATP citrate lyase (ACLY), farnesyl diphosphate synthase (FDPS), acetyl-
Coenzyme A carboxylase alpha (ACACA) and acetoacetyl-CoA synthetase (AACS)). 
Fasting also up-regulated expression of many genes involved in proteolysis and amino 
acid degradation. In addition to pathways highlighted by KEGG analysis, fasting down-
regulated a number of genes (e.g., TGFβ, BMP) that mediate mesenchymal stem cell 
(MSC) commitment, an early step in the formation of new adipocytes (Additional file 1). 
Finally, a number of phosphodiesterases were up-regulated with fasting, presumably in 
response to the increased plasma glucagon [58] and subsequent elevations in cyclic 
adenosine monophosphate (cAMP; Additional file 1). Collectively, these categories 
indicate that chicken adipose tissue responds to a relatively short duration (five hour) fast 
with sweeping changes in gene expression that suppress synthesis and storage of lipids 
and other macromolecules and up-regulate mobilization and metabolism of fatty acids 
and proteins. 
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Figure 2-1 Venn diagram of overlapping and unique effects of fasting and insulin 
neutralization on gene expression. (A) A total of 2016 unique genes were differentially 
expressed (FDR adjusted p-value <0.05) between one or more pairwise treatment 
comparisons; (B) A total of 1401 genes with absolute fold change ≥1.5 among the 
differentially expressed genes 
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Figure 2-2 Cluster analysis of differentially expressed genes. (A). Hierarchical cluster 
analysis of the 2016 genes (FDR adjusted p-value <0.05) that were differentially 
expressed between insulin-neutralized vs. fed and/or fasted vs. fed states. (B) Seven 
clusters (numbers) representing the most distinct effects of treatment were selected to 
further analyze expression profiles across treatments. Sample ID number on the X-axis 
corresponds to treatment group: sample 1–5, fasted; 6–10, insulin neutralized; 11–15,fed 
control. Y-axis represents relative gene expression value
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Table 2-1  Fold change verification of gene expression by RT-PCR 
  
Microarray 
Fold Change 
 
Quantitative PCR 
Fold Change 
Gene Symbol Gene Title 
Fasting 
vs. 
Fed 
Ins-Neu 
vs. 
Fed 
Ins-Neu 
vs. 
Fasting 
 
Fasting 
vs. 
Fed 
Ins-Neu 
vs. 
Fed 
Ins-Neu 
vs. 
Fasting 
FBXO8 F-box protein 8 4.16*** 2.09** -1.99***  2.59*** 2.76*** 1.06 
DUSP5 Dual specificity 
phosphatase 5 
9.43*** 1.05 -8.98***  8.13*** 1.69*** -4.82*** 
BNIP3 BCL2/adenovirus E1B 
19kDa interacting 
protein 3 
2.98*** 1.53 -1.95**  3.45*** 2.26*** -1.52* 
PBX3 Pre-B-cell leukemia 
homeobox 3 
-1.62*** 1.07 1.75***  -1.22 1.83*** 2.22*** 
IL10RB Interleukin 10 receptor, 
beta 
1.74*** 1.02 -1.71**  1.76*** 1.42* -1.24 
EGR1 Early growth response 1 2.43* -1.58 -3.86**  2.58*** -1.36 -3.52*** 
NAB1 NGFI-A binding protein 
1 (EGR1 binding protein 
1) 
2.43*** 1.06 -2.29***  1.67** 1.52** -1.10 
PDK4 Pyruvate dehydrogenase 
kinase, isozyme 4 
17.28*** 7.06** -2.45**  18.33*** 4.01*** -4.57*** 
CTSL2 Cathepsin L2 2.09*** 1.55* -1.35*  2.96*** 2.053*** -1.44 
AGTR1 Angiotensin II receptor, 
type 1 
4.15 *** 2.05* -2.02**  3.52** 1.72* -2.05* 
SESN1 Sestrin 1  1.86** 1.125 -1.65  1.58* 1.47* 1.07 
FDR p-value: * p < 0.05, ** p < 0.005, *** p < 0.0005 
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Table 2-2 Gene ontology (GO) and KEGG annotation for representative clusters of 
differentially expressed genes 
Cluster Annotat
ion 
GO term (Biological Process, level 6 or 7) or KEGG 
pathway name 
FDR 
 p-value 
1, 3 and 4 
(731 
genes) 
GO Positive regulation of protein metabolic process 6.0 E-3 
Negative regulation of cellular macromolecule biosynthetic 
process 
7.3 E-3 
 Triglyceride metabolic process 1.0 E-2 
 Negative regulation of gene expression 1.0 E-2 
 Proteolysis involved in cellular protein catabolic process 1.0 E-2 
 Negative regulation of kinase activity 1.5 E-2 
 Regulation of transcription, DNA-dependent 2.1 E-2 
 Protein phosphorylation 3.3 E-2 
 Antigen receptor-mediated signaling pathway 3.3 E-2 
 Regulation of phosphate metabolic process 3.4 E-2 
 Regulation of kinase activity 3.4 E-2 
 Regulation of I-kappaB kinase/NF-kappaB cascade 3.5 E-2 
KEGG Ubiquitin mediated proteolysis 1.0 E-2 
 Sphingolipid metabolism 1.8 E-2 
 PPAR signaling pathway 2.4 E-2 
 Fatty acid metabolism 4.6 E-2 
 Peroxisome  5.0 E-2 
2 
(557 
genes) 
GO Monosaccharide catabolic process 2.5 E-2 
DNA dependent DNA replication 3.6 E-3 
 Hexose metabolic process 1.1 E-2 
 Glucose metabolic process 1.4 E-2 
  Regulation of cell shape  1.5 E-2 
  DNA replication 1.5 E-2 
  Nucleoside triphosphate metabolic 2.3 E-2 
 KEGG Glycolysis / Gluconeogenesis 4.9 E-4 
  Citrate cycle (TCA cycle)  8.9 E-4 
6 
(402 
genes) 
KEGG  Steroid biosynthesis 4.4 E-3 
 
Glyoxylate and dicarboxylate metabolism 1.2 E-2 
  Pyruvate metabolism 3.3 E-2 
5 and 7 
(250 
genes) 
GO Enzyme linked receptor protein signaling pathway 9.7 E-3 
Regulation of cellular protein metabolic process  3.1 E-2 
  Negative regulation of macromolecule metabolic process  3.5 E-2 
  Transmembrane receptor protein serine/threonine kinase 
signaling pathway 
3.6 E-2 
 KEGG  PPAR signaling pathway 1.0 E-4 
  Glycerolipid metabolism 1.8 E-2 
  MAPK signaling pathway 4.6 E-2 
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Loss of insulin action also resulted in significant effects on adipose gene 
expression, the majority of which overlapped with the response to fasting (Table 2-3; 
Additional file 2). Several genes central to energy metabolism were affected. 
Diacylglycerol O-acyltransferase homolog 2 (DGAT2), which catalyzes the final and 
only committed step in tracylglycerol synthesis, was down-regulated (10.5-and 6.1-fold, 
respectively, fasted and insulin neutralized) in both treatment groups relative to the fed 
group. Conversely, acyl-Coenzyme A binding domain containing 5 (ACBD5) and 
pyruvate dehydrogenase kinase 4 (PDK4) were significantly up-regulated in both 
treatments relative to fed controls. ACBD5 is one of a family of long chain fatty acyl 
CoA trafficking protein proteins that play roles in both triglyceride synthesis and beta-
oxidation [142]. PDK4, which was up-regulated vs. fed by ~ 17-fold with fasting and 6-
fold with insulin neutralization, acts as a fuel switch by phosphorylating and inactivating 
pyruvate dehydrogenase, shifting metabolism from glycolysis to fatty acid oxidation 
[143]. Fasting and insulin neutralization also up-regulated expression of the type I 
angiotensin II receptor (AGTR1). Angiotensin II alters adipocyte lipid metabolism and 
insulin signaling [144-146], and increased AGTR1 expression in adipose tissue is 
associated with enhanced insulin sensitivity [147]. Finally, a number of genes regulated 
by both fasting and insulin neutralization function in general processes related to protein 
synthesis. 
A total of thirteen genes (four up-regulated and nine down-regulated) were 
differentially expressed only with insulin neutralization (Table 2-4). The most interesting 
of these responses were upregulation of GCG, which encodes preproglucagon (fold 
change = 2.91), in parallel with downregulation of the glucagon receptor (LOC425670, 
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fold change = −2.77). Other genes uniquely affected by insulin have less clear relevance 
to adipose biology according to current knowledge. 
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Table 2-3 Shared effects of fasting and insulin-neutralization on differential gene 
expression 
 
Gene Symbol Gene Title 
Fold change 
Insu-Neu    vs. Fed 
Fold change 
Fasting vs. Fed 
Up-regulated genes 
PDK4 
pyruvate dehydrogenase kinase, 
isozyme 4 
7.06 17.28 
AOX1 aldehyde oxidase 1 2.94 6.66 
PLEKHH2 
pleckstrin homology domain 
containing, family H (with MyTH4 
domain) member 2 
2.41 2.77 
FBXO8 F-box protein 8 2.09 4.15 
AGTR1 angiotensin II receptor, type 1 2.04 4.15 
PCMTD1 
protein-L-isoaspartate (D-
aspartate) O-methyltransferase 
domain containing 1 
1.99 2.25 
PSME4 
proteasome (prosome, macropain) 
activator subunit 4 
1.97 3.86 
ICA1 islet cell autoantigen 1, 69kDa 1.85 2.8 
IP6K2 inositol hexakisphosphate kinase 2 1.77 2.75 
UHRF2 
ubiquitin-like, containing PHD and 
RING finger domains, 2 
1.72 1.89 
ACBD5 
acyl-Coenzyme A binding domain 
containing 5 
1.72 2.51 
LOC417776 similar to hypothetical protein 1.62 1.84 
CTSL2 cathepsin L2 1.54 2.09 
ZNF217 zinc finger protein 217 1.54 2.6 
IFNAR1 
Interferon (alpha, beta and omega) 
receptor 1 
1.52 3.47 
Down-regulated genes 
DGAT2 
diacylglycerol O-acyltransferase 
homolog 2 (mouse) 
6.1 10.5 
EEPD1 
endonuclease/exonuclease/phosphat
ase family domain containing 1 
2.4 2.17 
ANKRD9 ankyrin repeat domain 9 2.19 1.98 
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Table 2-3 Continued  
Gene Symbol Gene Title 
Fold change 
Insu-Neu    vs. Fed 
Fold change 
Fasting vs. Fed 
Down-regulated genes 
DLST 
dihydrolipoamide S-
succinyltransferase (E2 component 
of 2-oxo-glutarate complex) 
1.95 1.76 
PTP4A3 
protein tyrosine phosphatase type 
IVA, member 3 
1.8 2.3 
HSPA5 
heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
1.76 1.74 
NOLA2 
nucleolar protein family A, member 
2 (H/ACA small nucleolar RNPs) 
1.73 1.57 
MST1R 
macrophage stimulating 1 receptor 
(c-met-related tyrosine kinase) 
1.71 2.2 
GRAMD2 GRAM domain containing 2 1.69 2.37 
DHDDS 
dehydrodolichyl diphosphate 
synthase 
1.63 1.58 
DYNLL2 dynein, light chain, LC8-type 2 1.6 2.52 
CDT1 
chromatin licensing and DNA 
replication factor 1 
1.57 1.51 
FAHD1 
fumarylacetoacetate hydrolase 
domain containing 1 
1.56 1.61 
DOT1L 
DOT1-like, histone H3 
methyltransferase (S. cerevisiae) 
1.56 1.82 
BTBD11 BTB (POZ) domain containing 11 1.55 1.71 
FDR p-value <0.05 
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Tissue metabolomic analysis was used to identify the metabolic intermediates that 
were altered by fasting and insulin neutralization. A total of 92 metabolites were detected 
based on signal-to-noise ratios (Additional file 3). It is worth noting that glucose-6-
phosphate content was similar in fasted or “diabetic” vs. fed status, despite a large range 
of plasma glucose levels (232–747 mg/100 ml). A total of 12 metabolites were 
significantly different between treatment groups based on p < 0.05 and an additional five 
were suggestive of significance (p < 0.10; Table 2-5). Tissue levels of amino acids were 
consistently lower in fasted vs. fed tissue, with statistically significant reductions in 
asparagine and glutamine (p < 0.01). Presumably, these effects were due to a change in 
the balance of protein synthesis/proteolysis and to the catabolism of carbon skeletons for 
energy in response to energy restriction, which is consistent with up-regulated expression 
of genes involved in amino acid catabolism (Figure 2-3). They may also reflect a 
decrease in plasma amino acid supply as suggested by the decrease in total plasma amino 
acid levels (evaluated by the content in total α-NH2-non-protein nitrogen (αNH2NPN), 
i.e., mostly total amino acids), as compared to fed controls [58]. In contrast to fasting, 
tissue amino acid levels tended to be increased in insulin-neutralized vs. fed, although 
only glutamine showed a statistically significant response. Comparison of insulin-
neutralized vs. fasted chickens highlights the divergent effects of treatments on amino 
acids (Figure 2-4). Alanine, arginine, asparagine, glutamine, histidine, proline, serine, 
threonine and tyrosine levels were all significantly higher in insulin-neutralized vs. fasted, 
with differences ranging from 1.7- to 3.4-fold. Two metabolites related to glucose 
metabolism, D-glucono-1,5-lactone 6-phosphate and glycerol-3-phosphate, were lower in 
both fasted and insulin-neutralized treatments vs. fed, with the latter comparison nearing 
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statistical significance (p < 0.1). D-glucono-1,5-lactone 6-phosphate is a product of 
glucose-6-phosphate dehydrogenase (G6PDH), an enzyme that, in mammals is insulin-
sensitive and rate-limiting for pentose phosphate pathway activity and production of 
cellular NADPH, an important cofactor for lipid metabolism [148]. However, pentose 
phosphate pathway activity is intrinsically low in chicken and is not stimulated when 
lipogenesis is high; the production of cellular NADPH is more closely related to malic 
enzyme activity [149]. Glycerol-3-phosphate is a product of both glucose and pyruvate 
metabolism and is used in triacylglycerol synthesis. Lower levels with both treatments 
may reflect glycerol demand for fatty acid reesterification in light of the apparent 
increase in lipolysis in both treatment groups [58]. 
Correlated patterns of gene expression and metabolite abundance were extracted 
using hierarchical clustering to interconnect treatment effects on transcripts and 
metabolites. Clusters 2 and 3 contained genes and metabolites with lower abundance in 
fasted vs. fed or insulin neutralized tissue. The two clusters differed with respect to the 
insulin neutralized group: cluster 3 contained analytes at intermediate levels between 
fasted and fed, while cluster 2 contained those at levels comparable to or greater than fed. 
Twelve of the 17 metabolites with statistically suggestive or significant effects of 
treatment, including all of the amino acids and amino acid derivatives (Additional file 4), 
were present in cluster 2 along with a set of genes that included the p85α regulatory 
subunit of PI3 kinase (PIK3R1), as well as ME, malonyl CoA decarboxylase and 
ELOVL6. Cluster 3 contained several metabolites including both NAD + and NADPH 
and was significantly enriched in GO annotations related to carbohydrate metabolism and 
in the KEGG pathways TCA cycle, glycolysis/gluconeogenesis, pyruvate metabolism and 
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steroid biosynthesis (p < 0.05; Additional file 4). Clusters 7 and 8 consisted of genes and 
metabolites with higher levels in fasted than in the other two treatment groups. These 
clusters were significantly enriched in GO categories PPAR signaling and negative 
regulation of cellular biosynthesis and also contained citrate and pyruvate (p < 0.05; 
Additional file 4). 
Discussion 
Despite roles as both a domestic food animal of worldwide economic importance 
and a widely used model organism with relevance for human obesity and insulin 
resistance, few studies have examined regulation of gene expression in chicken adipose 
tissue. To our knowledge, no studies of nutritional regulation of chicken adipose tissue at 
the genomic level have been reported in the published literature. Likewise, although 
insulin is the most well-defined hormonal mediator of metabolism in mammalian adipose 
tissue, its role in chicken remains to be clarified. Therefore the current study addressed 
two objectives: 1) characterize the transcriptomic and metabolomic response to energy 
manipulation as a step toward enhanced understanding of adipose biology in chicken; and 
2) identify the effects of insulin on chicken adipose tissue by including a group of birds in 
which insulin action was blocked by immunoneutralization with an anti-insulin antibody. 
We sought to both identify potential new targets for genetic selection or management 
strategies to reduce fat accumulation in commercial broilers and to further develop 
chicken as a model organism for studies of human obesity. 
Although intrinsic lipogenic activity is low in chicken adipose tissue, genes 
involved in fatty acid synthesis and storage were suppressed and those in fatty acid 
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mobilization and oxidation were up-regulated by fasting. The 40 down-regulated genes 
with fold changes greater than three were significantly enriched for the GO annotation 
lipid biosynthetic process (FDR <0.05), including genes that control triglyceride 
synthesis (DGAT2 and AGPAT9) and fatty acid synthesis (ACACA, ACLY and ME), 
elongation (ELOVL6), and desaturation (FADS1). AGPAT9 and DGAT2 catalyze the 
initial and final steps, respectively, of de novo triglyceride synthesis. ACLY is the main 
enzyme for synthesis of cytosolic acetyl-CoA, which is carboxylated to malonyl-CoA by 
ACACA, the rate-limiting step in fatty acid synthesis. Reducing equivalents for the 
conversion of malonyl-CoA to palmitate are supplied by malic enzyme (ME). ELOVL6 
catalyzes elongation of palmitate to stearate and appears to play a key role in insulin 
sensitivity [150, 151]. Finally, FADS1 is rate-limiting for polyunsaturated fatty acids 
(PUFA) biosynthesis and was recently implicated in control of fasting glucose 
homeostasis in humans [152]. Genes altered by fasting in adipose tissue in this study 
overlapped with those shown to be differentially expressed in chicken liver after 16 or 48 
hours of fasting, including ACLY, ACOX1, BCAT1 and PDK4 [153]. These authors 
used a different array platform than ours, which precludes precise quantitative 
comparisons. 
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Table 2-4 Unique effects of insulin neutralization on differential gene expression 
Up-regulated genes  Down-regulated genes  
Gene 
Symbol 
Gene 
Title 
Fold 
change 
Gene Symbol Gene Title Fold 
change 
GCG Glucagon 2.91 LOC425670 
glucagon 
receptor 
precursor 
2.77 
TCP11L2 
t-complex 
11 (mouse)-
like 2 
2.08 BAK1 
BCL2-
antagonist/killer 
1 
1.83 
LOC416916 
hypothetical 
LOC416916 
1.98 CCT3 
chaperonin 
containing 
TCP1, subunit 3 
(gamma) 
1.62 
MAGI1 
membrane 
associated 
guanylate 
kinase, WW 
and PDZ 
domain 
containing 1 
1.84 SETD7 
SET domain 
containing 
(lysine 
methyltransferas
e) 7 
1.62 
SEPT10 septin 10 1.79 ST13 
suppression of 
tumorigenicity 
13 (colon 
carcinoma) 
(Hsp70 
interacting 
protein) 
1.62 
LSM14A 
LSM14A, 
SCD6 
homolog A 
(S. 
cerevisiae); 
similar to 
LSM14 
homolog A 
(SCD6, S. 
cerevisiae) 
1.71 AHSA1 
AHA1, activator 
of heat shock 
90kDa protein 
ATPase homolog 
1 (yeast) 
1.62 
   TOE1 
target of EGR1, 
member 1 
(nuclear) 
1.59 
     AZIN1 
antizyme 
inhibitor 1 
1.56 
FDR p-value <0.05 
 
    56 
Table 2-5 Fold change of fasting and insulin neutralization on adipose tissue 
metabolites 
Metabolite Fasting/Fed Ins-Neu/Fed Ins-Neu/Fasting 
Adenosine 0.57 1.21 2.12* 
Alanine 0.66 1.57 2.38*** 
Arginine 0.75 1.34 1.78** 
Asparagine 0.47*** 1.00 2.15*** 
D-glucono-d-lactone-6-phosphate 0.86 0.75* 0.87 
Glutamine 0.48*** 1.64* 3.43**** 
glycerol-3-phosphate 0.82 0.72* 0.87 
Histidine 0.64 1.38 2.17*** 
Hypoxanthine 1.31 0.80 0.61** 
N-acetyl-glutamate 0.64 1.34 2.09* 
N-acetyl-L-serine 0.23** 1.70 7.30*** 
Ornithine 0.77 1.59 2.05* 
Proline 0.63 1.50 2.39*** 
Serine 0.67 1.61 2.39*** 
Threonine 0.77 1.38 1.80** 
Tyrosine 0.74 1.30 1.76** 
a hexose-phosphate 1.05 1.32** 1.26* 
* p < 0.10, ** p < 0.05, *** p < 0.01, **** p < 0.001 
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However, among the genes changed in both studies, the fold changes observed in 
adipose tissue were consistently greater than those in liver, despite the longer duration of 
fasting in that study. For example, PDK4 expression was up-regulated ~ 18-fold by a five 
hour fast in adipose tissue, but only ~ 1.5-fold after a 16 hour fast in liver. While 
differences in sensitivity between the two array platforms must be kept in mind, these 
data suggest that adipose tissue metabolism in chicken is at least as sensitive to energy 
status as hepatic metabolism. Our results indicate that both fatty acid synthesis and 
storage are dynamically regulated by energy status in chicken adipose tissue, despite its 
modest (~ 15%) contribution to the amount of stored fatty acids. 
Both fasted and insulin-neutralized birds exhibited significant increases in plasma 
glucagon. Parallel elevations in plasma NEFA suggested that this resulted in significant 
lipolysis of stored triacylglycerol in both treatment groups. During fasting, a considerable 
percentage of the liberated fatty acids are re-esterified in adipocytes, and only a small 
fraction traditionally have been thought to be oxidized in the mitochondria of adipocytes 
through beta oxidation [154]. However, recent studies in mice and in human adipose 
tissue demonstrate that in some conditions fatty acid oxidation in white adipose tissue is 
considerable and may be an important determinant of obesity [155-157]. Consistent with 
this concept, we found significant increases in a number of key enzymes that mediate 
mobilization of fatty acids and their oxidation, including the rate-limiting enzymes in 
both mitochondrial and peroxisomal fatty acid oxidation (CPT1A and ACOX1, 
respectively). We measured tissue levels of beta-hydroxybutyrate, a ketone product of 
beta oxidation, to confirm that changes in gene expression had functional consequences 
and found them to be significantly elevated in adipose tissue of fasted vs. fed chickens. 
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Levels were numerically but not statistically higher in insulin-neutralized adipose tissue 
(data not shown). Qualitatively, fasting-induced changes in gene expression resemble 
those induced by the fibrate class of drugs, which activate PPARα and promote fatty acid 
oxidation in white adipose tissue and are used clinically to treat hyperlipidemia [155, 
157-160]. These data suggest that dietary activation of PPARα, for example through 
supplementation with fatty acids that preferentially bind and activate this member of the 
PPAR family [161], may be a means to attenuate fat deposition in commercial broilers. 
Such action may underlie the reduced abdominal fat mass reported in broilers that were 
fed diets rich in n-3 PUFA[162]. 
Both fasting and insulin neutralization elicited marked upregulation of PDK4. 
PDK4 is a nutrient sensing fuel switch that phosphorylates and inactivates pyruvate 
dehydrogenase, which shifts fuel use from glucose to fatty acids and spares glucose for 
the brain during periods of fasting [143, 163-165]. PDK4 also enhances glycerol 
synthesis in white adipose tissue by shunting pyruvate into glyceroneogenesis, at least in 
the fed state [166]. Hepatic and skeletal muscle expression of PDK4 is increased by fatty 
acids, acetyl CoA, NADH and the diabetic state and decreased by insulin and pyruvate 
(rev. in [143, 167]). Little is known about PDK4 in chicken, but a recent study suggests it 
acts as a glycogen sensor in muscle and thus plays comparable roles to those in mammals 
[168]. In mouse white adipose tissue, PDK4 expression was shown to be induced by 
activation of p38MAPK [169], which we found to be significantly up-regulated with 
fasting and, to a lesser extent, with insulin neutralization [132]. Although PDK4 was up-
regulated in both treatment groups, and both groups showed evidence of increased 
lipolysis [58], only fasted chickens presented a gene expression signature and tissue beta-
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hydroxybutyrate levels that were clearly indicative of fatty acid oxidation. Although we 
did not measure malonyl-CoA levels, we predict that they were reduced with fasting, but 
not insulin neutralization, based on reduced expression of ACACA. Malonyl-CoA 
allosterically binds and inhibits CPT1A, minimizing fatty acid transport and subsequent 
oxidation in mitochondria [170]. With insulin neutralization, increased PDK4 may thus 
be more aligned with the demand for glycerol needed to reesterify fatty acids liberated by 
lipolysis [166]. Additional experiments are needed to confirm that manipulation of PDK4 
alters fatty acid oxidation in chicken adipose tissue and to delineate its relative 
contributions to fatty acid oxidation and glyceroneogenesis under varying metabolic 
states. If manipulation of PDK4 does alter fatty acid oxidation, our results highlight this 
pathway as a potential target for reducing fatness, which has relevance for both poultry 
and humans. 
Microarray data indicate that the effects of fasting in chicken adipose tissue 
extend beyond metabolism. GO analysis highlighted pathways such as cell cycle and 
cytokine-cytokine receptor interaction that are most likely related to changes in the 
stromal vascular fraction, which contains proliferating preadipocytes and cells of the 
immune system. In particular, a number of genes that regulate multiple steps in 
adipogenesis were significantly altered by fasting. Chickens rapidly accumulate 
abdominal fat after hatch, and until approximately 7 weeks of age this is due more to 
formation of new adipocytes than to adipocyte hypertrophy [127]. Adipocytes arise from 
mesenchymal stem cells in a two stage process of lineage commitment to an adipocyte 
fate, followed by differentiation of fibroblast-like preadipocytes into mature fat-storing 
cells [171]. Members of both the Wnt (MSC lineage commitment) and TGFβ/BMP (MSC 
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lineage commitment and preadipocyte competence) signaling pathways were 
significantly regulated by fasting. Fasting down-regulated expression of CEBPα and 
PPARγ, two transcription factors that orchestrate the cascade of gene expression changes 
that lead to terminal adipocyte differentiation [171]. Expression of other adipogenic 
mediators including fibroblast growth factor 2 (FGF2), fibroblast growth factor receptor 1 
(FGFR1) [172], and nuclear receptor corepressor 1 (NCOR1) [173] were also 
significantly regulated by fasting. Collectively, these changes suggest that adipocyte 
number in chickens is dynamically tied to energy status, at least in young chicks (such as 
those used herein) that are rapidly forming new adipocytes. An elegant study by Arner et 
al. concluded that adipocyte number in humans is a major determinant of adult fat mass 
and is determined during early childhood [174]. Less is known about this process in 
humans due to the limitations of sampling adipose tissue, particularly during 
development and from different abdominal depots. In light of what appears to be 
sensitive regulation of adipogenesis by nutritional state, chickens may thus be particularly 
valuable models in which to elucidate mechanisms of adipocyte hyperplasia during 
development that would inform the study of human obesity. 
It is worth noting that, despite the uncertainty about insulin signaling in chicken 
adipose tissue, fasting altered the expression of several messengers encoding elements of 
the insulin signaling cascade. Expression of PIK3CB, which encodes the catalytic p110 
subunit of PI3K, was up-regulated with fasting, while PIK3R1, which encodes the 
regulatory p85 subunit, was down-regulated. Such regulation could maintain some insulin 
signals despite a fall in plasma insulin level. CBLB and CRK, which mediate insulin 
signals that are associated with lipid rafts [175], were also up-regulated with fasting. In 
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mammals, this pathway stimulates glucose uptake independently of PI3K activation, 
which may shed light on the apparent refractoriness of PI3K activity to insulin that was 
described in chicken skeletal muscle [58]. Therefore, the potential effects of insulin on 
lipid storage and energy utilization appear to be defended in the fasting state, when 
insulin levels fall, by enhanced insulin sensitivity at the post-receptor level. Additional 
studies are needed to confirm this effect and to further explore the potential of PI3K-
independent effects of insulin on glucose utilization in chicken adipose tissue. 
Insulin is not considered to be a key regulator of glucose metabolism in chicken 
adipose tissue, although it does induce glucose disposal in chicken liver and muscle [62]. 
It is therefore not surprising that the majority of genes significantly altered by both 
insulin neutralization and fasting are not related to glucose metabolism and lipid 
synthesis. The main exception is DGAT2, which catalyzes the final step in esterification 
of fatty acids into triglycerides. In fact, DGAT2 showed the most extreme down-
regulation (6.1- and 10.5-fold, insulin-neutralized and fasted, respectively) in each 
treatment group, which is surprising considering that other genes related to lipogenesis 
were only regulated by fasting. Suppression of DGAT2 expression may be due to 
feedback by lipolysis, which appeared to be increased in both treatment groups based on 
plasma NEFA levels. In general, our data indicate that insulin deprivation altered fatty 
acid and glucose metabolism in a manner comparable to fasting but to a lesser extent, 
such that most genes involved in these pathways did not exhibit statistically significant 
changes in expression. For example, cluster analysis (Figure 3-2) revealed that some 
genes upregulated by fasting were also increased by insulin neutralization (clusters 1, 3 
and 4); these three clusters were enriched with genes in the KEGG pathways for fatty 
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acid metabolism and PPAR signaling, including both ACOX1 and CPT1A, among others. 
Similarly, among genes that were downregulated by fasting, clustering discriminated a 
set of genes (Figure 3-2, cluster 2) with a trend to also be decreased (albeit to a lesser 
extent than in fasting) by insulin deprivation. Interestingly, this cluster was significantly 
enriched in functions related to carbohydrate metabolism, suggesting that insulin does 
play some role in chicken adipose glucose metabolism. Comparable trends appeared in 
the metabolomic data. For example, stearate and palmitate (the only fatty acids measured 
by our MS platform) were lower (although not significantly) in both fasted and insulin 
neutralized compared to fed birds (Additional file 3). While the purpose of our study 
design was to determine the specific effects of insulin on chicken adipose tissue, we 
cannot exclude the possibility that some of the overlapping changes in gene expression 
were secondary to systemic factors, such as hyperglucagonemia present in both treatment 
groups [58]. In vitro experiments using primary adipocytes or adipose explants will be 
useful to confirm specific effects of insulin on genes identified herein. 
Of the 13 changes in expression that were unique to insulin neutralization, the 
most interesting responses were up-regulation of GCG, which encodes preproglucagon 
(fold change = 2.91), and down-regulation of the glucagon receptor (LOC425670, fold 
change = −2.77). The proglucagon system in avians is more complex than in mammals. 
The avian preproglucagon locus encodes two distinct precursor proteins that yield 
different peptides through alternative posttranslational processing: the class A transcript 
(PGA) yields glucagon and glucagon-like peptide-1 (GLP-1), while the class B transcript 
(PGB) additionally produces glucagon-like peptide-2 (GLP-2) and is more like the 
mammalian transcript (rev. in [176]). Adipose tissue expresses both transcripts, with 
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PGA being slightly more abundant, and is the third highest preproglucagon expressing 
tissue in chicken, behind pancreas and the proventriculus [177]. We used transcript-
specific QPCR to determine that only the PGB transcript was up-regulated by insulin 
neutralization (data not shown). Additional experiments are necessary to delineate which 
of the encoded peptides are up-regulated in parallel, but the coincident down-regulation 
of the glucagon receptor suggests a paracrine glucagon axis in chicken adipose tissue, and 
one that is regulated by insulin. In support of this concept, plasma glucagon (presumably 
derived largely from pancreas) was elevated comparably in both treatment groups [58], 
while GCG expression in adipose tissue was only up-regulated by insulin neutralization. 
Tissue metabolomic analysis highlighted effects of insulin neutralization that 
were divergent from fasting and not readily apparent from microarray data. Most of the 
tissue amino acids that were measured were higher with insulin-neutralization but lower 
with fasting when each group was compared to ad libitum fed controls. This pattern 
parallels the levels of αNH2NPN levels in blood [58]. Low levels in fasted adipose tissue 
were most likely due to oxidation of the carbon skeletons for cellular energy through the 
tricarboxylic acid cycle (TCA) cycle and/or for glyceroneogenesis, in the absence of 
dietary glucose. Increased amino acid catabolism was reflected in the differential 
expression profiles of the fasted vs. fed comparison (Figure 2-3; Additional file 1). In the 
insulin neutralized group, however, glucose supply from food was maintained and 
preferentially oxidized for energy. Elevated amino acids in the insulin neutralized group 
may also reflect reduced utilization due to the lack of insulin’s anabolic effects, 
particularly on the proliferating cell population within adipose tissue. The metabolomics 
approach used here measured only metabolite pool sizes at the time that tissues were 
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harvested, rather than the effect of fasting or insulin neutralization on the rates of 
metabolism through glycolysis and the TCA cycle. The latter would be much more 
informative with respect to the dynamic impact of treatment, but requires the use of 
isotopic labeling (e.g., by feeding 
13
C-labelled glucose) which was not performed in this 
study. Nonetheless, we were able to demonstrate significant effects on some metabolites 
that inform the parallel changes in gene expression, particularly in relation to amino acid 
metabolism. Combined clustering of metabolomic and gene expression together 
identified a set of genes correlated with many amino acid levels, including PIK3R1, ME 
and MCD. 
Conclusions 
In summary, we determined that adipose tissue metabolism in the chicken is 
regulated by energy status and, to a lesser extent by insulin. Although adipose tissue is 
not a primary site of lipogenesis in chicken, the rate-limiting genes for fatty acid 
synthesis were suppressed by fasting. Likewise, fasting appeared to increase aspects of 
insulin sensitivity based on expression profiles, despite the view that chicken adipose 
tissue is relatively insensitive to insulin. Consistent with this paradigm, insulin 
neutralization significantly altered the expression of only a few genes related to glucose 
and lipid metabolism. Nonetheless, a considerable number of genes were altered by 
insulin neutralization, many of which thus far have unclear roles in adipose biology. 
Expression profiles suggest that even short term fasting alters fat storage in broilers by 
enhancing the oxidation of fatty acids. The initiating events that trigger upregulation of 
the corresponding genes are unclear, but there is considerable evidence for activation of 
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PPARa, LXRa, and potentially other transcription factors that are activated by fatty acid 
ligands. Further studies are warranted to identify these triggers because of their potential 
impact on fat storage. Our data also suggest that broiler chicks may be an informative 
model organism in which to investigate dietary effects on adipose development in light of 
what appears to be a relationship between energy intake and adipogenesis. The results of 
this study thus have dual benefit for both the poultry industry and for studies of obesity in 
humans. 
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Figure 2-3 KEGG pathway analysis of genes differentially expressed in fasting vs. 
fed. Genes differentially expressed in fasting vs. fed were matched to KEGG pathway 
membership using ClueGO. The percentage and #genes/term indicates the percentage and 
number of the genes in the pathway that are contained in the set of genes altered by 
fasting. • p < 0.1 * p < 0.05 **, p < 0.01, based on Benjamini-corrected p-value 
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Figure 2-4 Heat map of metabolites. The median value of each metabolite in each 
treatment group was used to calculate fold-change of fasted vs. fed, insulin-neutralized 
(insneut) vs. fed, and insulin-neutralized vs. fasted, and then values were subjected to 
hierarchical clustering. 
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CHAPTER III 
GENETIC LEANNESS IN DOMESTIC CHICKENS IS 
ASSOCIATED WITH INCREASED FATTY ACID 
OXIDATION IN WHITE ADIPOSE TISSUE  
This manuscript will be submitted to Physiological Genomics with the following author 
list:  
Bo Ji, Jesse L. Middleton, Ben Ernest, Arnold M. Saxton, Susan J. Lamont, Shawn R. 
Campagna and Brynn H. Voy 
 
Introduction 
Domestic chicken has been intensively studied because of its role as an efficient 
source of lean meat. However, commercial broilers resulting from genetic selection for 
rapid growth demonstrate detrimental traits, such as excess deposition of abdominal 
adipose tissue, metabolic disorders, and reduced reproduction [178]. Of interest, such 
traits are also associated with human obesity [179]. Therefore, fast-growing broilers 
(meat-type) represent “obese” chickens compared to slow-growing egg layers (e.g, 
Leghorn) or wild-type strain chickens (e.g., Fayoumi) (rev. in [120]). Fayoumi chickens, 
originating from Egypt, represent a hardier stain of chickens that is more resistant to 
diseases [180]. Fayoumi has fast maturity and lays small eggs, which makes it a layer 
mostly raised in farms. Leghorn chickens are the original breed of commercial U.S 
layers. Both lines were maintained highly inbred by Iowa State University poultry 
geneticists with an inbreeding coefficient higher than 0.95. Both Fayoumi and Leghorn 
demonstrated lean phenotype compared to broilers, and these three lines of chickens are 
genetically distant from each other [181]. Specifically, chicken F2 populations generated 
from commercial broilers male line and two genetically distinct inbred lines (Leghorn 
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and Fayoumi) provide unique models through which to integrate phenotypes with 
genotypes. Genome-wide linkage analyses on F2 populations have identified QTLs 
associated with abdominal fat percentage [182], skeletal integrity, and metabolic traits in 
the chickens [111-114]. However, the genomic characterization of adipose tissue from 
the parental lines has not been studied yet.  
Additionally, study of egg-laying chickens provides insights to understand lipid 
mobilization, transfer and utilization for yolk precursor synthesis, which is important in 
deposition of yolk and embryo development [183].  Chickens also possess unique 
features, including natural hyperglycemia (up to 200 mg/dL in the fasting state) and 
resistance to exogenous insulin [121, 122], which mimic early stage of  type 2 diabetes in 
humans. Most of the genes located the quantitative trait loci (QTLs) regions for the 
fatness trait were found to be obesity and diabetes related genes in humans [115-117]. 
Unlike rodents, de novo lipogenesis in adipose tissue is relatively low in chickens and 
humans [123-125], which implicate the similarity of adipose metabolism between 
chickens and humans. Likewise, adipose cellular development is characterized by 
hyperplasia early in life through posthatching to first several weeks of age [78], and it 
paralleled hypertrophy through adulthood, and predominant hypertrophy at an older age. 
This correlates with the observations in humans that adult-onset obesity is associated with 
increased adipocyte size, whereas early-onset obesity has both adipocyte hypertrophy and 
hyperplasia [80].  
Previously, we identified pathways related to adipose metabolism, signaling and 
adipogenesis by characterizing the response of chicken adipose tissue to short-term feed 
restriction, which is a management practice in broiler industry to control fatness [184]. In 
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the present study, we assessed the physiological, transcriptomic and metabolomics 
variations on adipose tissue of three genetically distinct lines of chickens: Fayoumi (M 
5.1), Leghorn (Ghs-13) and commercial broilers. We aimed to 1) understand the adipose 
physiology of genetically distinct lines of chickens; 2) identify genes and pathways 
associated with the leanness of wild chickens, which are potential targets for control of 
fatness in broilers through either genetic selection or improved management practices. 
Plasma metabolites and endocrine parameters were investigated and abdominal adipose 
tissue transcriptomics and metabolomics were assayed by microarrays and LC-MS. The 
association of gene expression, metabolic and physiological responses was performed to 
provide a comprehensive understanding of the variation in fatness between broiler, 
Fayoumi and Leghorn.  
 
Methods and Materials 
Animals 
Male birds from broiler, Leghorn (Ghs-13) and Fayoumi (M5.1) lines maintained 
at the Iowa State University were sacrificed at week 7 by our collaborator in Dr. 
Lamont’s lab who provided tissue samples. All hatched chicks ( inbred Leghorn, inbred 
Fayoumi, and broilers) were wing-banded for individual pedigree identification. Birds 
were grown under standard management conditions from hatch to 7 weeks of age and had 
ad libitum access to water and feed. 
Determination of physiological parameters  
Body weight and fat weight were measured at week 7. Abdominal adipose tissue 
and serum samples from six birds of each line were collected and rapidly snap-frozen in 
liquid nitrogen, then stored at -80
o
C until analysis. Serum glucose levels were measured 
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by the glucose oxidase method using glucose colorimetric kit (Cayman, MI, USA). Free 
or non-esterified fatty acid (NEFA) levels and triglyceride (TAG) were determined using 
an enzymatic colorimetric kit (Wako Chemicals, Neuss, Germany). Glucagon and VLDL 
levels in the serum were determined by chicken glucagon ELISA kit and chicken VLDL 
ELISA kit (Novatein Biosciences, MA, USA). ß-hydroxybutyrate (b-HB) was determined 
by enzymatic colorimetric kit (Biovision, CA, USA). Lipid peroxidation was determined 
by measuring thiobarbituric acid reactive substrates (TBARS) (Cayman, MI, USA).  
Histological analysis of adipocyte size 
A portion of the abdominal fat pad was fixed in 4% paraformaldehyde then 
washed in PBS. The samples were embedded in paraffin, cut into 5μm sections, and 
stained with hematoxylin and eosin. Adipocyte size was measured using a previously 
established method [185]. Briefly, the tissue sections were viewed at 10X magnification, 
and images were obtained. The illumination of the images was adjusted using 
CellProfiler cell image analysis software  (www.cellprofiler.org). After the illumination 
was adjusted, the images were converted to a binary image in ImageJ (NIH; 
rsbweb.nih.gov/ij/) using the following commands: Gray Mode and Threshold. The 
binary images were further adjusted using Despeckle, Watershed, Erode, and Paintbrush. 
The cross-sectional area of the adipocytes was measured using the “Analyze particles” 
command. Approximately 200 adipocytes per chicken were measured.  
Gene expression 
Total RNA was isolated from chicken adipose samples using the RNeasy Lipid kit 
and incorporating an on-column DNase treated with the RNase-free DNase Set according 
to the manufacturer's protocol. RNA quality and concentration was measured using the 
Experion System (BioRad.com); only RNA passing recommended standards of quality 
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was used for further studies. Transcriptome profiling in chicken adipose tissue was 
performed by Genome Science Resource at Vanderbuilt University (Nashville, US) using 
the Affymetrix GenChip chicken genome array on the Affymetrix platform (San Diego, 
CA). For real time PCR validation, cDNA was synthesized using the iScript cDNA 
Synthesis kit. Commercially designed and validated primer sets (QuantiTect) primers 
were used in conjunction with the QuantiTect SYBR Green PCR kit on a CFX96 real-
time PCR detection system (Bio-Rad.com). RNA isolation and quantitative PCR (QPCR) 
reagents were obtained from Qiagen (qiagen.com). All samples were analyzed in 
triplicate and normalized to ß-tubulin. Relative differences in gene expression were 
determined using the ΔΔCT method (2-ΔΔCT as the fold change) and statistical differences 
were tested by analysis of variance (ANOVA) [134].   
Liquid chromatography coupled with tandem mass spectrometry (LC-
MS/MS) 
Abdominal adipose tissue samples from six birds of each line (the same six birds 
used for expression profiling) were extracted by placing tissue in a mortar containing 
liquid nitrogen and then powdering with a pestle. Portions (8 - 40 mg) of the powered 
tissue were weighed into 1.5 mL centrifuge tubes. Chilled methanol (0.3 mL at -80 
o
C) 
and internal standard (5 µL of 1.7 mM benzoic acid in negative mode or 4.25 mM tris 
(hydroxymethyl) aminomethane in positive mode) were added to each tube. Each tube 
was mixed thoroughly by vortexing for two minutes, and the metabolites were extracted 
from the tissue for 30 min at 4 
o
C. The tubes were then centrifuged (5 min, 4 
o
C, 16.1 rcf) 
and supernatant was removed. The extraction procedure was repeated for three times. 
Supernatant was split into two autosampler vials. One of these samples was immediately 
placed on the LC-MS/MS for analysis, while the other was stored at -80 
o
C for analysis in 
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the opposite polarity ion mode on the following day. The samples were placed in an 
autosampler tray chilled to 4 
o
C, and 10 µL of each was injected onto an LC column for 
analysis as described previously.    
Statistical analysis 
Statistical analysis of the microarray data was performed using R 2.13.0 and 
routines contained in Bioconductor (bioconductor.org) as described in previous study 
[184]. Statistical analysis of metabolomic data was performed using an analysis tool that 
we developed specifically for metabolomic data analyses [140]. The script (metabR), 
written in the language R, uses linear mixed-effect modeling to normalize metabolomics 
data for fat mass and internal standard  . The script averages any replicate measurements 
(statistical sampling) made on experimental units and performs ANOVA to test for 
statistical differences between experimental groups.  Body weight, fat weight, adipocity, 
and plasma levels of glucose, triglyceride, NEFA and TBARs were compared among 
groups using Tukey test in SAS 9.0. Distribution of adipocyte sizes was analyzed using 
propTable and plotted  in R 2.13.0.    
Results  
As expected, measures of fatness differ significantly between the three lines. 
Broilers are significantly fatter than Fayoumi and Leghorn in terms of body weight, fat 
weight, and adiposity (Table 3-1). The relationships between the physiological 
parameters were demonstrated using Pearson correlation coefficient (Table 3-2). 
Adipocyte size increased with fatness and differed significantly between each pairwise 
comparison, with the largest fat cells found in broilers and the smallest in Leghorn, the 
leanest of the three lines (Figure 3-1A). The number of very large adipocytes (>10000 
um
2
) was about 8% in the tissue of broilers, but less than 1% in Fayoumi and Leghorn 
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(Figure 3-1B). Plasma levels of non-esterified fatty acids (an index of lipolysis) and β-
hydroxybutyrate (a systemic measure of fatty acid oxidation) were significantly higher in 
lean chickens, i.e., Leghorn and Fayoumi, than broilers (p <0.05). Circulating VLDL 
levels were more than three times greater in broilers vs. Fayoumi, consistent with 
elevated VLDL in genetically selected fat lines of chickens [23, 24]. However, plasma 
level of VLDL in Leghorn was similar to broilers. Thiobarbituric acid reactive substances 
(TBARs), byproducts of lipid peroxidation, were higher in Fayoumi and Leghorn than 
broilers, but not statistically different. Plasma glucose and glucagon levels did not differ 
significantly between the three lines of chickens (data not shown).  
Physiological differences among the lean lines compared to broilers are paralleled 
by significant differences in adipose gene expression profiles. Expression levels of a total 
of 2361 genes were differentially expressed in Leghorn and/or Fayoumi compared to 
broilers based on an FDR adjusted p-value < 0.05 (Additional file 1; Figure 3-2A). 
Ninety-three percent (2212 of 2361) of these genes showed a fold-change > |1.5| (Figure 
3-2B). The number of genes that were differentially expressed in Fayoumi vs. broiler and 
Leghorn vs. broiler are essentially equivalent (1179 and 1354 genes, respectively).  
   Eleven genes of interest were selected based on fold-change or biological 
functions of interest based on our prior fasting study (Figure 3-2). Differential expression 
of PDK4, DUSP5, CCL20, TLR4, AGTR1 and NAMPT in Leghorn versus broilers was 
identified. Genes that were differentially expressed in Leghorn compared to broilers were 
also differentially expressed in Fayoumi except for AGTR1 based on real-time RT-PCR.  
All of the genes confirmed by QPCR as increased in lean vs. fatty lines were previously 
shown to be up-regulated in fasted vs. fed adipose tissue. 
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Hierarchical cluster analysis of the 2361 genes that were differentially expressed 
in at least one pairwise comparison was used to visualize the similarities and differences 
between groups. As shown in Figure 3-4A, birds within each of the three genetic lines 
clustered together. The dendrogram also shows that expression profiles in broiler adipose 
tissue were distant from those of Fayoumi and Leghorn, which were more similar to each 
other. Eight clusters representing different patterns were identified in terms of gene 
expression (Figure 3-4B). Four clusters (1, 3, 4 and 7) were of interest because their 
expression patterns qualitatively correlated with fatness (Figure 3-4). The genes in each 
cluster were submitted to Gene Ontology analysis, which provides the biological 
interpretation of the clusters and identifies significantly over-represented GO terms and 
pathways (Table 3-3).  
Cluster 1 contains genes expressed at higher levels in Fayoumi and Leghorn vs. 
broiler. This set of genes was significantly enriched in endocytosis, regulation of Ras 
protein signal transduction, fatty acid metabolic process and regulation of catabolic 
process.  Cluster 7 contains genes of the inverse pattern, with lower expression in 
Fayoumi and Leghorn compared to broiler. These genes are enriched in steroid 
biosynthesis, oxidative phosphorylation and negative regulation of low-density 
lipoprotein particle receptor biosynthetic process.  
Cluster 3 consists of genes with the highest expression in broiler and the lowest 
expression in Leghorn, corresponding to the two extremes in terms of degree of fatness. 
These sets of genes were significantly enriched in functions related to lipid biosynthetic 
process, cholesterol metabolic process and lipid metabolic process (Table 3-2). Contrary 
to cluster 3, cluster 4 contained genes with highest expression in Leghorn and lowest in 
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broilers. This set of genes represents a number of functional annotations, including 
calcium ion transport and cellular calcium ion homeostasis.  
GO enrichment was used to functionally annotate the set of 1233 genes that were 
differentially expressed between broilers and Leghorns, the leaner of the two lean lines. 
The biological process GO terms were used to characterize the genes differentially 
expressed in Leghorn versus broilers based on FDR<0.05 and absolute fold-change ≥1.5 
(Figure 3-5A). Leghorn differed from broilers in a diverse set of processes related to lipid 
and fatty acid metabolism and synthesis. This set of processes includes fatty acid and 
lipid biosynthetic processes, sterol and cholesterol biosynthetic and metabolic processes, 
fatty acid oxidation, lipid modification, fat cell differentiation, carboxylic acid catabolic 
process. Within these categories, the expression of genes involved in fatty acid oxidation 
(e.g, acetyl-CoA carboxylase beta (ACACB), carnitine palmitoyltransferase 1A 
(CPT1A), protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1)) were up-
regulated in Leghorn compared to broilers, while expression of genes that control fatty 
acid, sterol, cholesterol and triacylglycerol synthesis were down-regulated (e.g., 
Diacylglycerol O-acyltransferase homolog 2 (DGAT2), 3-hydroxy-3-methylglutaryl-
Coenzyme A reductase (HMGCR), stearoyl-CoA desaturase (SCD), farnesyl diphosphate 
synthase (FDPS), and acetoacetyl-CoA synthetase (AACS), fatty acid desaturase 1 and 2 
(FADS1 and FADS2 )). However, we also found that some genes in fatty acid oxidation 
(ACAD11, ACOX2) were down-regulated in Leghorn. Leghorn also showed up-
regulated expression of genes related to the regulation of adipogenesis (e.g., lipin 1 
(LPIN1), laminin alpha 4 (LAMA4), WNT inhibitory factor 1 (WIF1), transcription 
factor 7-like 2 (TCF7L2), tribbles homolog 2 (TRIB2), frizzled-related protein (FRZB), 
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aldehyde dehydrogenase 6 family (ALDH6A1)). Leghorn also had a lower expression of 
genes involved in antigen processing and presentation (e.g., major histocompatibility 
complex (MHC) Rfp-Y class I alpha (YFVI), MHC class I antigen (YFV), MHC class II 
antigen B-F minor heavy chain; MHC class II beta chain (BLB1), similar to MHC Rfp-Y 
class I alpha  MHC I-related (MR1)). The diversity of MHC was identified to be 
responsible for the genetic resistance to pathogens in chickens [186]. This is also 
consistent with the previous findings that Leghorn line was the most susceptible to 
pathogens [180].    
Genes in many of the same pathways were also differentially expressed in 
Fayoumi vs. broilers. Genes that differed between these two strains, based on FDR<0.05 
and absolute fold-change ≥1.5, were significantly enriched in fatty acid and lipid 
catabolic process, lipid modification, fatty acid oxidation, carboxylic acid catabolic 
process (Figure 3-5B). Among these categories, the genes that were up-regulated are 
involved in fatty acid oxidation (ACACB, ACAD11, ACOX2, EHHADH, PHYH, 
PRKAA1).   
Metabolic intermediates that were significantly altered in Leghorn and Fayoumi 
compared to broilers were identified. A total of 92 metabolites were detected based on 
spectral peak area (in ion counts) (Table 3-5). A total of 47 metabolites were different 
between treatment groups based on adjusted p<0.05. Metabolic intermediates of 
glycolysis/gluconeogenesis pathways, including phosphoenolpyruvate and 3-
phosphoglycerate, were significantly higher only in Leghorn vs. broilers (p<0.05), 
although the levels of glucose-6-phosphate, glycerol-3-phosphate and pyruvate were 
similar in Leghorn chickens vs. broilers. The accumulation of phosphoenolpyruvate and 
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3-phosphoglycerate may reflect the decrease in glycolysis or increase in gluconeogenesis 
in Leghorn chickens.  
Some metabolic intermediates (carnitine, acetylcarnitine, pentose phosphate, 
glycerophosphocholine, and UDP-N-acetylglucosamine (GlcNAC)) involved in lipid and 
carbohydrate metabolism were significantly higher in both Fayoumi and Leghorn, as 
compared to broilers. In contrast to Leghorn, tissue levels of amino acids were higher in 
Fayoumi vs. broilers, with statistically significant increase of threonine, proline, valine 
and ornithine. It is worth noting that NADPH, the reducing agent in lipid biosynthesis, 
was significantly decreased in Fayoumi vs. broilers (p<0.05).  Only 11 metabolites were 
significantly different in Fayoumi and Leghorn. Five metabolites (threonine, pantothenate, 
pyruvate, aspartate, and ox._Glutahion) were lower in Leghorn vs. Fayoumi, but the 
others (asparagine, 1-Methylhistidine, NADPH, Ethanolamine_or_Urea, 
Hypoxanthine_(NEG), 3-Phosphoglycerate)  were higher in Leghorn.  
Discussion                                   
Although attention has been drawn to domestic chickens because of their role as 
an important food animal, few studies have examined the transcriptomic and 
metabolomics differences of adipose tissue between different strains of chickens, 
specifically, egg-laying, meat-type chickens, and broilers. The primary objective of our 
present study was to define the transcriptomic and metabolomic characterization of 
distinct genetic lines of chickens that present different phenotypic traits to further 
understand adipose biology in domestic chickens. Secondly, we aimed to identify the 
association of genomic responses in adipose tissue with physiological and metabolic 
responses in chicken to solidify the status of chicken as a model organism for studies of 
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human obesity. We expected that the differences in gene expression and metabolites of 
three lines of chickens might explain the distinct phenotypic differences in the fatness of 
broilers and wild chickens.   
The lean phenotypes of Fayoumi and Leghorn were regulated by genes involved 
in various pathways and biological processes related to lipid and fatty acid biosynthesis 
and metabolism (Figure 3-6). Lipid accumulation in adipose tissue of chicken was 
considered partially through uptake of lipoproteins assembled in liver [41]. The candidate 
receptors responsible for lipid accumulation in adipose tissue include LDL receptor 
(LDLR), VLDL receptor (VLDLR) and LDL receptor-related protein (LRP) [187].  Our 
data demonstrated that the expression of LDLR and VLDLR were down-regulated in 
Leghorn vs. broiler. Apolipoprotein A1 (APOA1), a major protein component of high 
density lipoprotein (HDL) [36], was found to be significantly up-regulated in Leghorn. 
And LRP and VLDLR were down- regulated in Fayoumi. These results indicated there 
might be lower uptake of VLDL-triglycerides in adipose tissue of lean chickens 
compared to broilers. VLDL and vitellogenin (VTG) are major yolk precursors. Egg-
laying hens exhibit high plasma levels of VLDL and VTG at the onset of egg laying 
[188]. Therefore, the down-regulated VLDL receptor in adipose tissue of egg-type 
chickens was probably to accumulate VLDL in plasma.  
Genes differentially expressed in adipose tissue of Leghorn in this study 
overlapped with those altered by 5 hour fasting in adipose tissue of broilers, including 
genes enriched in lipids and cholesterol biosynthesis and fatty acid oxidation pathways 
[20]. The genes enriched in lipid biosynthetic process were down-regulated, but in fatty 
acid oxidation were up-regulated in white adipose tissue of Leghorn compared to broilers.  
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Acetoacetyl-CoA synthetase (AACS) was down-regulated (2.1- fold) in Leghorn vs. 
broiler. AACS catalyzes the formation of acetoacetyl CoA, which is the precursor of 
HMG-CoA, initializing cholesterol synthesis. Additionally, a number of genes (ACAT2, 
FDPS, IDL1, SQLE, LSS, SC4MOL, NSDHL, HSD17B7, DHCR7, DHCR24) involved 
in the whole mevalonate pathway were significantly down-regulated in Leghorn vs. 
broiler.  Diacylglycerol kinase, theta (DGKQ) was down regulated (4.3-fold) in Leghorn 
vs. broiler. DGKQ is a member of diacylglycerol kinases family that metabolize 
1,2,diacylglycerol (DAG) to produce phosphatidic acid (PA). Together with the down 
regulation of DGAT2 and elevated tissue level of glycerolphosphocholine, our results 
indicate that the energy consumed may contribute to the synthesis of phosphatidylcholine 
by increasing glycerolphosphocholine instead of TAG or PA in adipose tissue of Leghorn.   
Interestingly, we found PDK4, one of the most markedly up-regulated genes by 5 
hour fasting in adipose tissue of chicken, was greatly up-regulated (5.5- fold) in Leghorn 
vs. broiler. PDK4 phosphorylates and inactivates pyruvate dehydrogenase, functioning as 
the fuel switch that shifts fuel use from glucose to fatty acids during fasting. PDK4 may 
also contribute to glyceroneogenesis or gluconeogenesis by shunting pyruvate for 
glycerol synthesis or enhancing substrate for gluconeogenesis [189, 190]. Increased tissue 
levels of phosphenolpyruvate and phosphoglycerate, intermediates of glyceroneogenesis 
and gluconeogenesis pathways, confirmed this concept. Thus, upregulation of PDK4 in 
both lean chickens and fasted chickens indicate that PDK4 could be a potential target to 
manipulate for reducing fatness in chickens.  Expression of other genes related to fatty 
acid oxidation, such as lipin-1 and CPT1A, were significantly up-regulated in Leghorn vs. 
broilers based on fold-change. Lipin-1 was recently shown to amplify PPARα and Pgc-1α 
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activity, further enhancing fatty acid oxidation in liver [191]. Additionally, elevation of 
tissue levels of carnitine and acetylcarnitine in lean chickens further confirmed increased 
fatty acid oxidation. Carnitine and acetylcarnitine, the activated form of carnitine, play an 
important role in fatty acid oxidation by transporting long-chain acyl groups from fatty 
acids into the mitochondrial matrix. This process is accomplished by the carnitine 
palmitoyltransferase (CPT) system. CPT1A is rate-limiting enzyme initiating the 
mitochondrial oxidation of long-chain fatty acids. Consistent with upregulation of genes 
and metabolites in fatty acid oxidation, we also found elevations in plasma NEFA and B-
hydroxybutyrate, which suggested elevated lipolysis and fatty acid oxidation in lean 
chickens.   
In addition to fatty acid metabolism, the cluster of genes enriched in calcium ion 
transport and cellular calcium ion homeostasis represent the unique characterization of 
Leghorn as a layer line.  Differential expression of this set of genes may result from the 
selection on higher egg and eggshell weight in layers, which require high amounts of 
calcium for the formation of eggshells [192].   
In contrast to Leghorn, genes (HIBCH, ALDH2, ALDH3A2, ALDH6A1, 
EHHADH, MCD, MUT, SUCLG2) enriched in functions related to propionate 
metabolism were up-regulated in Fayoumi vs. broilers. Enoyl-CoA, hydratase/3-
hydroxyacyl CoA dehydrogenase (EHHADH), which is an L-bifunctional enzyme 
involved in classical peroxisomal fatty acid β-oxidation pathway, was recently 
recognized as indispensable enzyme for the production of medium-chain dicarboxylic 
acids [193]. Malonyl-CoA decarboxylase (MCD), the enzyme responsible for 
decarboxylation of malonyl-CoA to acetyl-CoA, was significantly up regulated (3.78-fold) 
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in Fayoumi. Increased MCD activity resulted in an elevated rate of fatty acid oxidation in 
liver and heart by rapidly decreasing malonyl –CoA level [194-196]. Methylmalonyl 
CoA mutase (MUT) and succinate-CoA ligase (SUCLG2) are responsible for conversion 
of propanoyl-CoA (a product of beta-oxidation of odd-chain fatty acids or BCAA) to 
succinyl-CoA for energy [197]. Similarly, Hydroxyisobutyryl-CoA  Hydrolase (HIBCH) 
catalyzes the pathway for the metabolism of branched-chain amino acid (BCAA) and 
propionate, indicating the increased proteolysis to provide energy. A recent study 
demonstrated that SUCLG2 and HIBCH were up regulated  in the lipodystrophic mice 
model [198]. Aldehyde dehydrogenases (ALDHs), a superfamily of NAD(P)(+)-
dependent enzymes with similar primary structures, catalyze the oxidation of a wide 
spectrum of endogenous and exogenous aliphatic and aromatic aldehydes to fatty acids 
[199]. Three genes (ALDH2, ALDH3A2, ALDH6A1) encoding enzymes of ALDHs 
family were up-regulated in Fayoumi. Aldehyde dehydrogenase enzymes produce 
NADPH, which is consistent with higher levels of NADPH in Fayoumi vs. broilers. The 
substrates of ALDHs are the products of lipid peroxidation, therefore elevated ALDHs 
may be due to higher lipid peroxidation, which was confirmed by higher serum TBAR 
level in Fayoumi chickens. However, some of these genes (EHHADH, MCD, HIBCH, 
and ALDH2) were down-regulated in Leghorn, as compared to broilers. The distinct 
regulation of the same genes in propionate metabolism pathway in Fayoumi and Leghorn 
reflected their preference for energy sources. Leghorn mainly utilized energy from 
oxidation of long chain fatty acids instead of oxidation of carbohydrate, whereas 
Fayoumi consumed energy from oxidation of medium chain fatty acids and/ or 
metabolism of amino acids from elevated proteolysis.  
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Gene expression profiling of adipose tissue indicated that the features that 
distinguished the three lines of chickens from each other are not limited to metabolism. In 
particular, GO analysis demonstrated that genes were enriched in fat cell differentiation 
pathway in Leghorn. Mesenchymal stem cells (MSC) give rise to adipocytes by lineage 
commitment, preadipocytes proliferation, and differentiation. CEBPa, the transcription 
factor that triggers the adipocyte differentiation, was significantly down-regulated in 
Leghorn vs. broiler. However, adipose differentiation-related protein (ADFP) was 
significantly up-regulated in Leghorn. ADFP is specific marker for lipid accumulation, 
whereas, it was also found to be induced by long chain fatty acid, PPARa and fasting in 
liver [200, 201].  The expression of adipogenic mediators, including fibroblast growth 
factor 2 (FGF2) and fibroblast growth factor receptor 3 (FGFR3), was significantly 
down-regulated in Leghorn compared with broilers. Additionally, the substantial up-
regulation of Wnt inhibitory factor 1 (WIF1, 44.8-fold) in Leghorn vs. broiler indicates 
the inhibition of Wnt (MSC lineage commitment) signaling in Leghorn [202]. In contrast, 
these genes ((WIF1),  adiponectin (ADIPOQ), and chibby (CBY1) ) were down-regulated 
in Fayoumi [203]. In agreement with data of adipocyte sizes, Leghorn showed dramatic 
changes of genes in the development of adipocytes, while the changes in Fayoumi were 
minimal. It worth noting that transcription factor 7-like 2 (TCF7L2) was significantly 
differentially expressed in both Leghorn and Fayoumi vs. broilers. TCF7L2 was found to 
be associated with type 2 diabetes in adults and impaired glucose metabolism in children 
[204]. This implicates the potential application of chicken as a model to study human 
obesity and diabetes.  
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Leghorn and Fayoumi demonstrated different expression of genes related to 
insulin signaling cascades. Expression of inositol hexakisphosphate kinase (IP6K2) was 
up-regulated in Leghorn vs. broilers. Expression of PIK3CB and PIK3C2A, which 
encode isoforms of class I and class II of PI3Ks respectively [205], were up-regulated in 
Fayoumi vs. broilers. Expression of PRKAA1 and PRKAB2, which encode catalytic and 
regulatory subunits of the 5 prime AMP-activated protein kinase (AMPK), were up-
regulated (21- and 2- fold, respectively)  in Fayoumi vs. broilers, whereas only PRKAA1 
was up-regulated in Leghorn.  AMPK plays a major role in ACC and MCD regulation by 
phosphorylating and inactivating ACC activity, but activating MCD activity, which 
favors fatty acid oxidation [206].  Thus, the marked increase of PRKAA1 may be 
responsible for the transcriptional alteration of genes in fatty acid oxidation in lean 
chickens.  A recent study found activation of AMPK inhibits PPARa and PPARy 
transcriptional activity in hepatoma cells [207], which may result in insignificant changes 
of PPARa and PPARy  in lean chickens. 
In summary, we determined that adipose tissue metabolism in lean chickens is 
distinct from that in broilers. The leanness of Leghorn (layer) and Fayoumi (meat type) 
were regulated by various pathways related to lipid and fatty acid biosynthesis and 
adipogenesis. Expression profiles indicated that fatty acid metabolism was altered from 
storage toward oxidation in lean chickens. Our data also suggest the differences in 
adipose metabolism between layers and meat type chickens. This study is beneficial to 
both obesity study and poultry science.  
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Table 3-1. Physiological parameters of three lines of chickens.  
 
 
 Broiler Fayoumi Leghorn  
body weight (g) 2208.2±214.1
a
 524.1±35.5 
b
 415.19±18.2
 b
  
fat weight (g) 20.0±5.6
a
 3.3±1.8
b
 1.5±0.8
b
  
Fat/BW 0.009±0.0002
a
 0.006±0.0002
b
  0.004±0.00018
c
  
non-esterified fatty acid (mM) 0.21±0.03
c
 0.41±0.07
a
 0.29±0.04
b
  
triglyceride (mg/dL) 57.99±14.8
b
 98.96±32.3
a
 56.55±25.6
b
  
ß-hydroxybutyrate (mM) 0.34±0.05
c
 0.57±0.07
a
 0.44±0.05
b
  
TBARS (uM) 2.2±0.7
a
 3.1±1
a
 2.6±0.7
a
  
very low density lipoprotein 
(ug/ml) 
0.085±0.027
a
 0.024±0.0025
b
 0.070±0.019
a
  
glucagon (pg/ml) 76.7±11.6
a
 82.6±20.2
a
 84.1±5.5
a
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Table 3-2 Correlation of physiological parameters 
Variable by Variable Correlation p-value 
adiposity fat weight 0.58 0.02278 
ß-hydroxybutyrate  Triglyceride 0.73 0.00187 
ß-hydroxybutyrate  body weight -0.69 0.00406 
ß-hydroxybutyrate  fat weight -0.63 0.01263 
fat weight body weight 0.94 1.1E-07 
NEFA adiposity -0.73 0.00188 
NEFA fat weight -0.57 0.02712 
TBARS ß-hydroxybutyrate  0.53 0.04326 
VLDL TBARS -0.63 0.01126 
VLDL fat weight 0.62 0.01324 
VLDL body weight 0.56 0.02868 
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Table 3-3.  Gene ontology (GO) and KEGG annotation for representative clusters of 
differentially expressed genes.    
 
Cluster  Annotat
ion 
GO term (Biological 
process, level of 6 or 7) 
or KEGG pathway 
name 
FDR  
p-value 
Genes 
1  
(180 
genes) 
KEGG 
Ribosome biogenesis in 
eukaryotes 
9.7 E-3 
[HEATR1, REXO1, SBDS, 
TBL3] 
  
Melanogenesis 1.2 E-2 
[CREB3L2, FZD6, MITF, 
TCF7L2] 
  
Endocytosis 3.8 E-2 
[BF2, GIT2, RAB22A, 
VPS4B] 
 GO ncRNA metabolic 
process 
3.9 E-2 
[INTS2, INTS6, SBDS, 
TBL3] 
  Regulation of Ras protein 
signal transduction 
4.2 E-2 
[ARFGEF1, FGD3, FGD4, 
GIT2, GPR65] 
  
Fatty acid metabolic 4.4 E-2 
[ACACB, HPGD, LPIN1, 
PRKAA1] 
  Regulation of small 
GTPase mediated signal 
transduction 
4.6 E-2 
[ARFGEF1, FGD3, FGD4, 
GIT2, GPR65] 
  Regulation of catabolic 
process 
5.0 E-2 
[ADRA1B, GIT2, GPR65, 
PRKAA1, UVRAG] 
2 
(260 
genes)  
GO Regulation of sequence-
specific DNA binding 
transcription factor 
activity 
2.0 E-2 
[FZD4, HCK, ID2, PRKCH, 
VEGFA] 
  
Peptidyl-amino acid 
modification 
2.1 E-2 
[ADH5, CD3E, CSRP2BP, 
HCK, PDK3, PRMT7, 
VEGFA, WEE1] 
  
Brain development 3.8 E-2 
[FZD4, GPR56, ID2, NPY, 
SLC4A7, ULK1] 
  Peptidyl-tyrosine 
phosphorylation 
4.3 E-2 
[CD3E, HCK, VEGFA, 
WEE1] 
  Peptidyl-tyrosine 
modification 
4.3 E-2 
[CD3E, HCK, VEGFA, 
WEE1] 
  Regulation of 
neurogenesis 
4.5 E-2 
[DLL1, ID2, PRKCH, 
ULK1, VEGFA] 
  Ribonucleotide metabolic 
process 
4.6 E-2 
[ATP1B1, GART, TMED2, 
UMPS] 
 KEGG Phagosome 1.9 E-2 
 
[ATP6V0A1, BLB2, 
COMP, MARCO] 
3 (439 
genes 
KEGG Terpenoid backbone 
Biosynthesis 
2.6 E-4 
[ACAT2, FDPS, HMGCR, 
IDI1, PDSS1] 
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Table 3-3 Continued 
Cluster  Annotat
ion 
GO term (Biological 
process, level of 6 or 7) 
or KEGG pathway 
name 
FDR p-
value 
Genes 
  
Steroid biosynthesis 7.9 E-4 
[DHCR7, LSS, NSDHL, 
SC4MOL] 
  
Metabolic pathways 3.2 E-3 
[ACAT2, ACLY, ACOX2, 
ACSS3, AK2, ALDH2, 
ALDH4A1, ALG11, 
ATP6V0E1, DEGS1, 
DGKQ, DHCR7, EXTL3, 
FDFT1, FDPS, HMBS, 
HMGCR, HPRT1, IDI1, 
LSS, MMAB, NADSYN1, 
NDUFA11, NDUFB2, 
NSDHL, OXSM, PAPSS1, 
PLA2G6, PLCD1, PRDX6, 
QDPR, SC4MOL, SQLE, 
WBSCR17] 
 GO Lipid biosynthetic 
process 
5.5 E-3 
[DEGS1, DHCR7, FDFT1, 
FDPS, HMGCR, IDI1, LSS, 
NSDHL, OXSM, PDSS1, 
PLA2G6, SC4MOL, SCD, 
ST8SIA6] 
  Cholesterol metabolic 
process 
8.8 E-3 
[CEBPA, DHCR7, FDPS, 
HMGCR, LSS, NSDHL] 
  Lipid metabolic process 
2.9 E-2 
[AACS, ACAD11, ACOX2, 
CEBPA, DEGS1, DHCR7, 
FDFT1, FDPS, HMGCR, 
IDI1, LSS, NSDHL, OXSM, 
PDSS1, PLA2G6, PLCD1, 
PRDX6, SC4MOL, SCD, 
ST8SIA6] 
  Alcohol metabolic 
process 4.3 E-2 
[CEBPA, DHCR7, FDPS, 
HMGCR, HPRT1, LSS, 
NSDHL, SNCAIP] 
4 
 (296 
genes) 
 
GO 
Regulation of 
transmembrane transport 
3.5 E-2 
[BCL2, CACNG4, GNA11, 
TRPV2] 
  
Calcium ion transport 3.6 E-2 
[BCL2, LOC395914, 
SLC24A2, TRPV2] 
  Cellular calcium ion 
homeostasis 
4.3 E-2 
[AGTR1, BCL2, 
LOC395914, SLC24A2] 
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Table 3-3 Continued 
Cluster  Annotat
ion 
GO term (Biological 
process, level of 6 or 7) 
or KEGG pathway 
name 
FDR p-
value 
Genes 
  Regulation of membrane 
potential 
4.4 E-2 
[ADAM22, BCL2, GNA11, 
UGT8] 
  Positive regulation of cell 
development 
4.6 E-2 
[BCL2, CDH4, DCT, 
TRPV2] 
5  
(300 
genes) 
 
KEGG Biosynthesis of 
unsaturated fatty acid 
1.5 E-3 
[ELOVL5, FADS1, FADS2, 
PTPLB] 
 
  Endocytosis 
2.9 E-2 
[ACAP2, CHMP1B, EGFR, 
KIT, LDLRAP1, 
RCJMB04_3g13, SMAD7, 
STAM] 
 
6 
 (151 
genes) 
 
GO 
Fat cell differentiation 2.1 E-3 
[ARID5B, EIF2AK3, 
LAMB3, SOD2, TCF7L2] 
  Regulation of 
neurological system 
process 
1.0 E-2 
[ATAD1, EIF2AK3, 
LAMA2, TCF7L2] 
  Regulation of 
transmission of nerve 
impulse 
1.4 E-2 
[ATAD1, EIF2AK3, 
LAMA2, TCF7L2] 
  
Multicellular organismal 
signaling 
3.2 E-2 
[ATAD1, CAMK4, 
EIF2AK3, LAMA2, 
TCF7L2] 
  
Transmission of nerve 
impulse 
3.6 E-2 
[ATAD1, CAMK4, 
EIF2AK3, LAMA2, 
TCF7L2] 
  Oxidation-reduction 
process 
4.3 E-2 
[NDUFB4, NDUFB8, 
SOD2, TALDO1] 
  Cellular amino acid 
metabolic process 
4.8 E-2 [BCKDHB, BHMT, MUT, 
SOD2] 
7  
(473 
genes) 
KEGG Steroid biosynthesis 
4.2 E-2 
[DHCR24, HSD17B7, LIPA] 
 
  Oxidative 
phosphorylation  
5.0 E-2 
[ATP5G3, ATP5O, 
ATP6V1C2, COX6C, 
COX7A2L, NDUFA10, 
NDUFA2, NDUFC2] 
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Table 3-3 Continued 
Cluster 
Annotat
ion 
GO term (Biological 
process, level of 6 or 7) 
or KEGG pathway 
name 
FDR p-
value 
Genes 
 GO Negative regulation of 
low-density lipoprotein 
particle receptor 
biosynthetic process 
2.8 E-2 [ADIPOQ, ITGAV] 
  
Myeloid cell 
differentiation 
3.0 E-2 
[ADD1, ADIPOQ, CAMK4, 
HMGB2, JAG1, LMO2, 
NDFIP1, PRDX3, TESC] 
  Negative regulation of 
macrophage derived 
foam cell differentiation 
3.3 E-2 [ADIPOQ, ITGAV] 
  Regulation of myeloid 
cell differentiation 
3.7 E-2 
[ADIPOQ, HMGB2, JAG1, 
LMO2, NDFIP1, TESC] 
 8 
 (262 
genes) 
KEGG Lysine degradation  5.0 E-2 [ASH1L, PLOD2, 
SUV420H1] 
 
  Rgulation of neuron 
projection development 
4.2 E-2 
[CCDC88A, GOLGA2, 
LYN, PSEN1, PTEN] 
  Negative regulation of 
transferase activity 
4.5 E-2 
[LYN, PRDX3, PSEN1, 
PTEN] 
  Peptidyl-tyrosine 
phosphorylation 
4.7 E-2 
[IL31RA, JAK1, LYN, 
PDGFRA, PSEN1] 
  Peptidyl-tyrosine 
modification 
4.7 E-2 
[IL31RA, JAK1, LYN, 
PDGFRA, PSEN1] 
  Negative regulation of 
kinase activity 
4.9 E-2 
[LYN, PRDX3, PSEN1, 
PTEN] 
  
Regulation of neuron 
differentiation 
4.9 E-2 
[BMP6, CCDC88A, 
CDK5RAP2, GOLGA2, 
LYN, PSEN1, PTEN] 
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Table 3-4 Correlation of Adipocyte size with 53 common genes identified by three 
pairwise contrasts.    
Gene Correlation        Signif Prob 
PQLC3 -0.95 7.31E-08 
SQLE 0.94 1.34E-07 
DCT -0.94 2.19E-07 
SYT15 -0.91 3.27E-06 
TMEM164 0.89 8.00E-06 
LOC100859544 -0.89 1.03E-05 
FAS -0.88 1.24E-05 
RDM1 -0.88 1.39E-05 
CEP170 0.88 1.48E-05 
USPL1 -0.88 1.75E-05 
WIF1 -0.86 4.75E-05 
IFI27L2 -0.86 4.86E-05 
LOC420414 -0.84 7.54E-05 
GNL3 -0.84 1.03E-04 
CXCR4 0.82 1.75E-04 
RASD1 0.81 2.33E-04 
LACE1 0.78 6.49E-04 
MTMR2 0.71 2.98E-03 
NHP2L1 0.70 3.78E-03 
MPZL1 0.65 8.60E-03 
PON2 0.61 1.58E-02 
HEY1 -0.59 1.97E-02 
NMRAL1 0.59 2.00E-02 
VLDLR 0.58 2.41E-02 
DCAF6 -0.58 2.41E-02 
ALDH6A1 -0.57 2.54E-02 
ERGIC1 -0.52 4.86E-02 
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Table 3-5 Fold change of adipose tissue metabolites in pairwise comparisons of three 
strains (broiler, Leghorn, and Fayoumi) 
Metabolites 
Fayoumi-
Broiler 
Leghorn-
Broiler 
Leghorn-
Fayoumi 
ox._Glutahione_or_DG 5.28*** 0.87 0.16** 
Threonine_(POS) 4.11*** 1.46*** 0.36*** 
Pantothenate 1.65*** 0.63*** 0.38*** 
Oxidized_Glutathione_(GSSG) 2.49** 1.20 0.48 
Pyruvate 1.43*** 0.74 0.52*** 
1-Methyladenosine 5.76*** 3.21*** 0.55 
Pentose_Phosphate 3.73*** 2.09*** 0.56 
Ornithine 2.65*** 1.54 0.58 
IMP 0.89 0.53*** 0.60 
Nicotinamide_Ribotide 1.99** 1.34** 0.67 
Aspartate 1.73** 1.23 0.71** 
Reduced_Glutathione_(GSH) 1.88** 1.38*** 0.73 
Ceramide 1.93 1.42 0.74 
Lysine-(67) 2.15*** 1.62*** 0.75 
Proline 1.90** 1.45** 0.76 
Carnitine 3.44** 2.69*** 0.78 
Lysine-(84) 1.77** 1.41*** 0.80 
Valine 1.62** 1.33*** 0.82 
Acetylcarnitine_DL 3.57*** 2.94*** 0.82 
Deoxyguanosine 2.03*** 1.71** 0.84 
Guanosine 3.17*** 3.03*** 0.95 
5prime-Methylthioadenosine 2.16*** 2.13** 0.98 
Glycerophosphocholine 2.48*** 2.53*** 1.02 
Taurine 1.48*** 1.59** 1.08 
Guanine 2.35*** 2.62*** 1.11 
Creatinine 1.77*** 2.03** 1.14 
Riboflavin 1.40 1.65** 1.17 
N-Acetylglucosamine-1-
Phosphate 1.73*** 2.10** 1.22 
Serine 1.32*** 1.64** 1.25 
Xanthine_(POS) 1.59** 2.04*** 1.29 
Lactate 0.78** 1.00 1.29 
Malate 1.30 1.81*** 1.39 
Cytidine 1.44 2.01*** 1.39 
Nicotinamide 1.07 1.54** 1.43 
Asparagine 0.99 1.55*** 1.56*** 
Adenosine 2.19** 3.47*** 1.59 
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** p < 0.05, *** p < 0.01, **** p < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-5 Continued     
Metabolites 
Fayoumi-
Broiler 
Leghorn-
Broiler 
Leghorn-
Fayoumi 
Cytosine 2.76** 4.39*** 1.59 
Citrulline 2.06*** 3.29*** 1.59 
Glycerol-3-Phosphate 0.64 1.10 1.71 
deoxyribose 1.97** 3.61*** 1.83 
Ethanolamine_or_Urea 1.91** 4.07*** 2.13** 
Imidazoleacetic_Acid 2.02 4.33*** 2.15 
1-Methylhistidine 1.13 2.48*** 2.19*** 
Hypoxanthine_(NEG) 1.33 3.13** 2.36** 
3-Phosphoglycerate 0.96 3.46*** 3.61** 
NADPH 0.31*** 1.24 4.02** 
Phosphoenolpyruvate 1.39 7.42*** 5.33 
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Figure 3-1. A. Histology of abdominal adipose tissue from broiler, Fayoumi and 
Leghorn. Scale bar: 500 μm. B. Adipocyte area was measured using ImageJ 
software. Mean adipocyte area in broiler, Fayoumi and Leghorn (n = 7/group).  C. 
the distribution of adipocyte area. When letters above bars differ, means significantly 
differ by p<0.05.  
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Figure 3-2. QPCR results for selected genes in chickens. Results are expressed as 
fold change determined using the ΔΔCt method. Blue: broiler, red: Fayoumi, green: 
Leghorn. *p<0.05, **p<0.01. ***p<0.001  
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Figure 3-3. Venn diagram of overlapping and unique effects of Leghorn and 
Fayoumi vs. broiler (a) A total of 2361 genes were differentially expressed (FDR 
adjusted pvalue <0.05) between one or more pairwise treatment comparisons; (b) A total 
of 2212 genes with absolute fold change ≥1.5 among the differentially expressed genes.   
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Figure 3-4. Cluster analysis of differentially expressed genes. The 2361 genes 
differentially expressed in one or both inbred chickens vs. broilers were subjected to 
hierarchical clustering to visualize similarities and differences between breeds. (a). 
Hierarchical cluster analysis of the 2361 genes (FDR adjusted pvalue <0.05) that were 
differentially expressed between  Leghorn vs. broiler and/or Fayoumi vs. broilers. (b) 
Expression profiles of eight clusters extracted by hierarchical cluster. Sample ID number 
on the X-axis corresponds to treatment group: sample 1-6, broiler; 7-11, Fayoumi; 12-17, 
Leghorn. Y-axis represents relative gene expression value.  
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Figure 3-5 KEGG pathways analysis of genes differentially expressed genes. Genes were matched to KEGG pathway membership 
using ClueGO. (A) Leghorn vs. broiler. (B) Fayoumi vs. broiler (C) Leghorn vs. Fayoumi. The percentage and #genes/term indicates 
the percentage and number of the genes in the pathway that are contained in the set of genes differentially expressed in different 
breeds of chicken. • p < 0.1 * p < 0.05 **, p < 0.01, based on Benjamini-corrected p-value  
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Figure 3-6 Shared traits of naturally lean chickens.  
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CHAPTER IV 
 GENE EXPRESSION SIMILARITIES BETWEEN FASTED 
AND LEAN PHYSIOLOGIES IN DOMESTIC CHICKENS 
This manuscript will be submitted to Poultry Science with the following author list:  
Bo Ji, Ben Ernest, Arnold M. Saxton, Susan J. Lamont, and Brynn H. Voy 
 
Introduction 
 
Obesity in humans may be attributable in part to decreased oxidation of fatty 
acids in skeletal muscle, the primary contributor to whole body fatty acid oxidation.  
Fatty acid oxidation is impaired systemically, and specifically in skeletal muscle, in obese 
vs. normal weight patients [208-210].  Obesity is associated with a variety of metabolic 
changes, however, it is difficult to determine which is the cause and which is the 
consequence of the obese state. Nonetheless, some studies suggest that impaired fatty 
acid oxidation is a primary defect that contributes to the development of obesity.  Normal 
weight subjects with a family history of obesity were shown to have lower rates of fatty 
acid oxidation than individuals with no family history [211]. Further, normal weight 
children with an obese parent also exhibit reduced fatty acid oxidation in muscle  [212], 
suggesting a genetic component to fatty acid oxidation that is inked to leanness.  
Little is known about the role of fatty acid oxidation in the control of leanness in 
chickens. In our previous studies (Chapters 2 and 3), we found gene expression profiles 
indicative of increased fatty acid oxidation in adipose tissue of fasted broilers vs. fed and 
in genetically lean Leghorn and Fayoumi lines compared to broilers. We therefore 
reasoned that fasting and genetic leanness may share common features in terms of 
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adipose tissue metabolism, including increased fatty acid oxidation. To explore this 
possibility, we conducted a combined analysis of gene expression profiles from the 
fasting and insulin-neutralization study and from the study of broilers, Leghorn and 
Fayoumi. The two studies were performed in different countries and with differences in 
husbandry, age of animals and other unknown confounds. We also compared the effects 
of fasting and leanness on adipose metabolism signalling pathways using Western blot 
analyses and on the fatty acid composition of adipose tissue using GC-MS. Part of the 
Western blot results described in this chapter were previously published in [68]. 
Methods 
Quantification of fatty acids with gas chromatography/mass spectrometer 
(GC/MS) 
 
Fatty acids samples were prepared for GC-MS analysis following the steps of 
lipid extraction, triglyceride hydrolyzation, esterification and methylation of fatty acids 
according to the methods described [208-210]. Nonadecanoic acid was used as an 
internal control. Approximately 10-50 mg adipose tissue was homogenized using 2:1 
chloroform:methanol. Lipids were extracted in the organic phase by centration. Lipids 
were hydrolyzed using 0.3 M KOH in methanol and incubated at 80°C for 60 minutes. 
Boron trifluoride (BF3, 12-15%) in methanol was used as an acid catalyst for 
esterification and transesterification.  In esterification, a methyl group from methanol is 
added to the carboxyl group of free fatty acids at 90°C for 90 minutes.  Fatty acids were 
reconstituted in hexane for GC-MS analysis. The fatty acid methyl ester was analyzed 
using a gas chromatography system, Agilent 6890 GC G2579A system (Agilent) 
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equipped with an OMEGAWAX 250 capillary column (Supelco) and a flame ionization 
detector. An Agilent 5973 mass selective detector was used to identify target peaks. 
Western blotting  
Western blotting was used to determine the effects of fasting and insulin 
neutralization  on insulin and stress signaling by investigating the protein levels of 
phosphorylated and total AKT, ERK, AMPK, S6K, mTOR, p38 (Cell Signaling). Protein 
lysates was prepared by tissue extraction buffer (Invitrogen) supplemented with protease 
and phosphatase inhibitor (Roche). Proteins were detected using ECL Plus 
chemiluminescent substrate (gelifesciences.com) and intensity of signals following 
hybridization was measured using a chemiluminescent detector (Versadoc; bio-rad.com).  
Statistical analysis 
Statistical analysis of the microarray data was performed using R 2.13. Data 
normalization and processing was performed as described previously [184]. Statistical 
significance of gene expression differences were analyzed by two-way ANOVA 
(treatment (T) and country (C) factors) and empirical bayes using the limma package.  
Differential expression was defined based on false discovery rate (FDR) adjusted p-value 
<0.05. Venn diagrams of differentially expressed genes were plotted to visualize the 
number of differentially expressed genes for each factor and interaction of factors.  
Hierarchical clustering of significant genes was performed using the hclust function and a 
hierarchical clustering heatmap was created using heatmap.2 in the gplots package.  
The model (Equation 1) was based on defining treatment level 1 as fasted 
chickens (France) and lean Leghorn (US), and treatment level 2 was broilers from both 
countries. Country factor represent the variations associated with geographical and 
husbandry effects.  
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Yij=μ+Ti +Cj+T*Cij                  (1) 
The difference between birds for each fatty acid was evaluated by analysis of 
variance (ANOVA) and post hoc Tukey test for multiple comparisons in SAS (SAS 
Institute, Cary, NC). The correlation coefficients of phenotypic traits and gene expression 
were based on Pearson correlation.   
Results  
Mega-analysis of Affymetrix data from different studies 
Two-way ANOVA model identified that 1587 genes were differentially expressed 
in terms of treatment, and 1919 genes in terms of country factor, and 390 genes affected 
by the interaction of treatment and country based on an FDR adjusted p-value < 0.05. The 
genes of interest are 1049 genes (954 genes of them with fold change> 1.5) that were 
only altered by treatment, but not by country and/ or interaction of treatment and country 
(Figure 1A).   
Hierarchical cluster analysis was employed based on 1049 genes that were only 
significantly altered by treatment factor. As shown in Figure 1B, broilers fed ad libitum 
were clustered with broilers, whereas fasted birds were clustered together with lean 
Leghorn chickens. Five clusters representing different patterns were identified in terms of 
gene expression denoted by the color bar (Figure 1B). The genes in cluster 1 (493 genes) 
were of interest because they showed very consistent low expression in lean and fasted 
chickens, but high expression in broilers. These genes were submitted to DAVID Gene 
Ontology analysis, which provides the biological interpretation of the clusters and 
identifies significantly over-represented GO terms and pathways (Table 1).   
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Effects of fasting and insulin neutralization on phosphorylation of Akt, 
MAPKs ERK1/2, mTOR, S6K, AMPK, and P38MAPK in chicken adipose 
tissue 
The effects of fasting and insulin neutralization on phosphorylation of Akt, 
AMPK, MAPKs ERK1/2, mTOR, S6K and P38 insulin signaling pathways were 
evaluated in chicken adipose tissue (Figure 4-2). Our results suggested that 
phosphorylation of Akt, ERK1/2, S6K were decreased by fasting and insulin-
neutralization in chickens. However, there was no significant effect of fasting and 
insulin-neutralization on phosphorylated level of mTOR and AMPK. Interestingly, 
fasting significantly increased MAPK P38 phosphorylation in chicken adipose tissue.  
Phosphorylation of Akt, MAPKs ERK1/2, S6K, AMPK, and P38MAPK in 
adipose tissue of lean and broilers 
Our data suggested that the phosphorylated levels of Akt, MAPKs ERK1/2, S6K 
and P38MAPK were similar between Leghorn, Fayoumi and broilers. Nevertheless, 
phosphorylated level of AMPK was higher in Fayoumi vs. broilers (Figure 4-3).  
Effect of fasting and insulin neutralization on compositions of fatty acids  
Compositions of most fatty acids were not altered by fasting and insulin 
neutralization, except for cis-vaccenic  (18:1( n-7)) and linoleic acid (18:2 (n-6)), which 
were statistically significant lower in fasted vs. fed chickens (p<0.05). However, absolute 
concentrations of fatty acids are consistently lower in fasted chickens than in fed 
chickens (data not shown). There was no significant difference of fatty acid compositions 
in insulin neutralized chickens compared to ad libitum fed chickens.  
Compositions of fatty acids in Leghorn, Fayoumi and broilers 
Oleic acid (18:1 (n-9)), a monounsaturated fatty acid, is the most abundant fatty 
acid in chicken adipose tissue, accounting for about 40% of total fatty acids. The 
    105 
abundance of oleic acid was significantly lower in Leghorn than broilers (p<0.05). 
Compositions of some other fatty acids, including myristic acid (14:0), palmitic acid 
(16:0), stearic acid (18:0), and linoleic acid (18:2 (n-6)), were significantly higher in 
Leghorn vs. broilers and Fayoumi (p<0.05). Consequently, the ratios of saturated fatty 
acids to unsaturated fatty acids were significantly higher in Leghorn vs. broilers and 
Fayoumi (p<0.05).  Interestingly, docosahexaenoic acid (DHA, 22:6 (n-3)) was 
significantly higher (p<0.05) in Leghorn vs. Fayoumi, as was the ratio of EPA and DHA 
to AA, which is the ratio of n-3 to n-6. In contrast, Fayoumi had similar compositions of 
fatty acids as broilers, except that Fayoumi had the highest abundance of oleic acid, and 
the highest ratio of n-3 to n-6 among the three lines of chickens.  
Correlation of physiological responses and gene expression 
The correlations of physiological responses to fasting and insulin neutralization 
and gene expression were investigated. Variables with correlation coefficients higher 
than 0.7 (p<0.001) were considered as strongly correlated. Plasma triodothyronine (T3) 
was highly correlated with expressions of a large number of genes (901 genes). Plasma 
glucose was highly correlated with 140 genes. Plasma glucagon and NEFA were highly 
correlated with 143 genes and 525 genes, respectively. Some of the genes were both 
highly correlated with plasma levels of hormones and metabolites (Figure 4-4). 
Interestingly, eight unique genes that are only highly correlated with glucagon include 
GCG, ST13, and TCP11L2, which were also identified as uniquely differentially 
expressed in insulin neutralized chickens.  
Discussion 
We sought to identify similarities in gene expression signatures between leanness 
and feed restriction by integrating the array data generated from previous studies.  
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However, the true effect of the treatment was confounded by geographical and husbandry 
factors associated with these distinct studies. To account for these confounding 
experimental factors, we first developed a linear model to identify the effect of the 
confounding factor and its interactive effect with treatment, then excluded the genes that 
were affected by the confounding factor and its interaction with treatment. The genes that 
were only affected by treatment factor were submitted for hierarchical clustering and 
Gene Ontology analysis. Two-way ANOVA model identified the similarities between 
fasting broiler and naturally lean chickens. Cluster 1 contained genes with lower 
abundance in Leghorn and fasted chickens  vs. broilers were significantly enriched in 
fatty acid biosynthetic and metabololic process, steroid and carboxylic acid biosynthetic 
process (Benjamini adj. pvalue<0.05). Cluster 2 and 3 consisted of genes with higher 
expression in lean and fasted chickens compared to broilers. These clusters were enriched 
in genes involved in immune responses and in fatty acid oxidation, including PDK3, 
PDK4, ACACB, and CPT1A. This method increased power and accuracy to detect 
differentially expressed genes in fasted broilers and lean chickens compared to fed 
broilers, regardless of breeds, geographical and husbandry factors. Furthermore, it 
identified the similarities of fasted broilers and naturally lean Leghorn lying in the 
categories characterized by decreased fatty acid biosynthesis and increased fatty acid 
oxidation.  
Chickens are considered to be refractory to insulin. Chicken muscle showed 
insulin resistance, but only in the early steps of insulin signaling [58, 67]. Moreover, 
genetically fat and lean line chickens showed apparent difference in insulin signaling in 
response to feeding, prolonged fasting and refeeding. Fat line chickens exhibited higher 
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insulin sensitivity in liver than lean line chickens in terms of early steps (IRß, IRS-1, Shc 
and PI3K) of insulin signaling cascade, which would account for increased liver 
lipogenesis in fat line chicken [64]. Nevertheless, little difference was observed in leg 
muscle of fat line chickens regarding the early steps of insulin signaling in response to 
nutritional status, which may be due to consistent refractory to insulin in muscles [64]. 
However, little is known about chicken adipose tissue. In this study, we assessed 
phosphorylated levels of insulin signalling cascades in chickens from both studies to 
characterize the effects of fasting and insulin on signalling pathways, and insulin 
signalling cascades in different breeds of chickens.  
In terms of the effects of fasting on insulin signaling pathways, the genes up or 
down stream of AKT, ERK and mTOR signaling pathways were significantly 
differentially expressed in fasted chickens, such as DUSP5, MYC, MAP3K5. 
Consistently, decreased phosphorylated levels of AKT, ERK, mTOR and p70S6K were 
observed in fasted chickens. AMPK, which is considered as energy sensor, is activated in 
response to nutrient deficiency or stress to support cellular metabolism and maintain the 
ATP cellular level. However, the activation of AMPK by 5-hour fasting was not 
significant (Fig. 3).  For the stress signaling, TLR4 and TNFR6, which are up-stream of 
JNK signaling pathways were up-regulated. It is consistent with the activation of p38 and 
indicated the promotion of inflammation in adipose tissue through the released fatty acids 
by fasting.  As described in Chapter 3, we found that Expression of PRKAA1 and 
PRKAB2, which encode catalytic and regulatory subunits of AMPK, were up-regulated 
(21- and 2- fold, respectively)  in Fayoumi vs. broiler adipose tissue. Correspondingly, 
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phosphorylated level of AMPK was higher in Fayoumi than broilers, whereas the 
difference was not observed in Leghorn chickens.  
AMPK plays a major role in ACC and MCD regulation by phosphorylating and 
inactivating ACC activity, but activating MCD activity, which favors fatty acid oxidation 
[206].  Together with increased expression of genes involved in fatty acid oxidation, 
activation AMPK further implicated favored fatty acid oxidation in lean chickens. 
Additionally, PDK4 expression was shown to be induced by activation of p38MAPK in 
mouse white adipose tissue [169], which was also observed in adipose tissue of fasted 
and lean chickens.  
Like humans, but unlike rodents, oleic acid is the most abundant fatty acid in 
adipose tissue of chickens[211]. Linoleic acid (18:2) is an essential fatty acid not 
synthesized in the body of animals, which is derived from diet. Linoleic acid was higher 
in Leghorn, which only indicated the differences in their feed uptake.  Leghorn had less 
unsaturated fatty acids and more saturated fatty acids than broilers, which is different 
from previous studies on mice. Obese mice had significant increases in saturated fatty 
acids, and a significantly decrease in unsaturated fatty acids. The opposite result in lean 
chicken is propably due to the egg-laying feature of Leghorn, which have their specific 
features of lipid homeostasis and fatty acids transfer to maintain follicular cells and form 
the yolk. Another reason for increased saturated fatty acids may be due to their different 
expression of fatty acid elongase. Fatty acid elongase 6 (ELOVL6) is the rate-limiting 
elongase related to de novo lipogenesis. Pigs carrying the allele associated with a 
decrease in ELOVL6 gene expression had increased C16:0 and C16:1 (n-7) fatty acid 
content and a decrease of elongation activity ratios in muscle and backfat [212]. This may 
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explain higher composition of palmitic acid in Leghorn than broilers, since ELOVL6 was 
up-regulated in Leghorn.  
Leghorn contained higher percentage of DHA, which is beneficial to humans by 
providing natural source of n-3 PUFA and also indicated the higher anti-inflammatory 
modulations in lean chickens. Dietary intake of n-3 PUFA reduced the incidence of 
myocardial infarction and chronic inflammatory or autoimmune disorders[213].  EPA 
and DHA reduce adiposity in humans and rodents either by increasing fatty acid 
oxidation in liver and adipose tissue or by inhibiting hepatic lipogenesis [214]. EPA and 
DHA also activates AMPK in adipose tissue and cultured adipocytes. Increased ratio of 
n-3 PUFA to n-6 PUFA in Fayoumi may be the reason for increased phosphorylated 
levels of AMPK in adipose tissue of Fayoumi chickens compared to broilers. DHA is 
synthesized through peroxisomal beta oxidation by shortening C24:6 n-3 [52]. An 
increase in DHA also implicated increased occurance of fatty acid oxidaiton in lean 
chickens compared to broilers.   
Collectively, our results provided further evidence that the leanness of Leghorn 
and Fayoumi are associated with increased fatty acid oxidation in adipose tissue.  Our 
results also provide an important basis to understand the potential connections between 
fasting, leanness and adipose inflammation, so that we can go further to investigate the 
relationship between nutritional status, fat deposition and the innate immune system in 
poultry.   
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Figure 4-1. A. Venn diagram of differential expressed genes (adjusted 
pvalue<0.05) in terms of treatment factor, country factor and their 
interaction. B. Hierarchical cluster analysis of the 1049 genes (FDR 
adjusted pvalue <0.05) that were differentially expressed in terms of 
treatment.  The colour bar denotes five clusters extracted by 
hierarchical cluster.  
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Figure 4-2. Western blots revealed increased abundance of phosphorylated 
p38MAPK and decreased phosphorylated ERK1/2 and S6K 
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Figure 4-3.  Western blots revealed increased abundance of phosphorylated 
p38MAPK  in Fayoumi chickens 
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Table 4-1. Fatty acids composition in adipose tissue of broiler, Leghorn and 
Fayoumi 
  Broiler Leghorn Fayoumi 
     
myristic acid 14:00 0.0035a 0.0045b 0.0031a 
myristoleic acid 14:1 (n-5) 0.0005a 0.0003a 0.0003a 
palmitic acid 16:00 0.1672a 0.2168b 0.1445a 
cis-7-hexadecenoic acid 16:1 (n-9) 0.0032ab 0.0026a 0.0029a 
palmitoleic acid 16:1 (n-7) 0.0374ab 0.0213a 0.0245a 
stearic acid 18:00 0.0392a 0.0669b 0.0429ab 
oleic acid 18:1 (n-9) 0.4933b 0.3644a 0.5566c 
cis-11-octadecenoic acid  
(cis-vaccenic) 
18:1 (n-7) 0.0079a 0.0076a 0.0089a 
linoleic acid 18:2 (n-6) 0.2426a 0.3113b 0.2124a 
cis-5,8,11,14,17-
Eicosapentaenoic acid 
(EPA) 
20:5 (n-3) 0.0048ab 0.0040b 0.0038a 
arachidonic acid (AA) 20:4 (n-6) 0.0002ab 0.0001a 0.0001a 
all-cis-4,7,10,13,16,19-
Docosahexaenoic acid 
(DHA) 
22:6 (n-3) 0.0002a 0.0003b 0.0002a 
 16:0/16:1 4.1214a 9.0468b 5.2659a 
 18:0/(18:1+18:2) 0.0527a 0.0979b 0.0551a 
 EPA+DHA/AA 27.9042a 45.5205b 60.4438c 
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Table 4- 2. Fatty acids composition in adipose tissue of broiler ad libitum, fasted for 
5 hours and insulin-neutralized 
  Fasting Fed Insu-Neu 
     
myristic acid 14:00 0.0022 0.0021 0.0023 
myristoleic acid 14:1 (n-5) 0.0002 0.0002 0.0003 
palmitic acid 16:00 0.0704 0.0640 0.0687 
cis-7-hexadecenoic acid 16:1 (n-9) 0.0033 0.0027 0.0031 
palmitoleic acid 16:1 (n-7) 0.0218 0.0236 0.0213 
stearic acid 18:00 0.0351 0.0320 0.0335 
oleic acid 18:1 (n-9) 0.6708 0.6305 0.6187 
cis-11-octadecenoic acid 
(cis-vaccenic) 
18:1 (n-7) 0.0093a 0.0204a 0.0117a 
linoleic acid 18:2 (n-6) 0.1838a 0.2213a 0.2378a 
cis-5,8,11,14,17-
Eicosapentaenoic acid 
(EPA) 
20:5 (n-3) 0.0026 0.0026 0.0022 
arachidonic acid (AHA) 20:4 (n-6) 0.0002 0.0002 0.0002 
all-cis-4,7,10,13,16,19-
Docosahexaenoic acid 
(DHA) 
22:6 (n-3) 0.000278ab 0.000344a 0.000265b 
 16:0/16:1 2.8091 2.4349 2.8144 
 18:0/(18:1+18:2) 0.0516 0.0491 0.0532 
 EPA+DHA/AA 16.1839 12.6882 15.9688 
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Figure 4-4.  Four-way venn diagram of overlapping and unique genes highly 
correlated with plasma glucose, glucagon, NEFA, and T3.  
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CHAPTER V 
CONCLUSIONS AND FUTURE PERSPECTIVES  
We used an approach that couples comprehensive transcriptomic and 
metabolomic methods with system and cellular physiology to identify the mechanisms 
that regulate fat deposition in domestic chickens. The results are summarized as below: 
A short term (5-hour) fast impacted expression of genes in a broad selection of 
pathways related to metabolism, signaling and adipogenesis. Fasting up-regulated rate-
limiting genes in both the mitochondrial and peroxisomal pathways of beta-oxidation. 
Short term fasting suppressed adipogenesis; expression of key genes in multiple steps of 
adipogenesis, including lineage commitment from mesenchymal stem cells, were 
significantly down-regulated in fasted vs. fed adipose tissue. Microarray analysis of 
Fayoumi, Leghorn and broiler adipose tissue revealed that genetic leanness shared 
molecular signatures with the effects of fasting. Fatty acids components were 
significantly different between lean chickens and broilers. Chicken adipose tissue is 
refractory to insulin. Collectively, these data suggest that leanness in chickens is 
associated with increased fatty acid metabolism toward oxidation, rather than storage.  It 
is surprising because white adipose tissue is not traditionally considered a site of 
significant fatty acid oxidation, which is more for muscle. Previous studies focused on 
fatty acid oxidation in liver and muscle, and ignored the occurrence of fatty acid 
oxidation in adipose tissue. Our study, for the first time, comprehensively investigated 
the association of adipose metabolic and physiological responses with gene expression in 
avian. Our study also identified the unique features of adipose metabolism of naturally 
lean chickens (layer and meat type) compared to broilers. These results also highlight 
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chicken as a useful model organism in which to study the dynamic relationship between 
food intake, metabolism, and adipose tissue biology. 
  Based on the findings of our studies, future studies will focus on reduction of fat 
deposition by regulation of lipolysis and fatty acid oxidation and the mechanism behind 
the effect of lipolysis and fatty acid oxidation. For example, does lipolysis induce 
activation of macrophages? Does overexpression of PDK4 in adipose tissue lead to 
increased fatty acid oxidation and reduced fatness? A tissue specific overexpression or 
knockout of PDK4 experiment is helpful to answer this question. Furthermore, how do 
fatty acid components dynamically change with lipolysis and fatty acid oxidation? It 
would also need to be determined if oxidative stress is associated with increased fatty 
acid oxidation.  
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